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Role and Regulation of Myosin IIA in Natural Killer Cell Cytotoxicity
Abstract
Natural killer (NK) cells are lymphocytes of the innate immune system that provide defense by directing
their cytotoxic activity against virally infected and tumorigenic cells. Target cell lysis requires directed
secretion of lytic granule contents, including pore-forming perforin and apoptosis-inducing granzymes, at
the contact site. During the formation of a mature immunological synapse (IS) with a target cell, an NK
cell polymerizes filamentous actin (F-actin) at the contact site, which may serve as a barrier to secretion
of lytic granules for cytotoxicity. An actin-based motor protein, nonmuscle myosin IIA, has been
demonstrated to be required for NK cell cytotoxic activity. In this work, we examine the role of myosin IIA
in NK cell cytotoxicity. Through studies of primary human NK cells and NK cell lines, we find that myosin
IIA associates with NK cell lytic granules. This functional association is required for NK cell granule
exocytosis because myosin IIA mediates an interaction of lytic granules with F-actin at the IS. We find that
NK cell cytotoxicity is impaired in patients with mutations in the myosin IIA heavy chain, and that
mutations in the motor domain and nonhelical tailpiece specifically affect NK cell function. Finally, we
demonstrate that single molecules of myosin IIA associate with NK cell lytic granules via the nonhelical
tailpiece of the myosin IIA heavy chain, and that this interaction requires phosphorylation of the tailpiece
at Ser1943. Thus, we present a novel role for nonmuscle myosin IIA in NK cells, where myosin IIA directly
associates with lytic granules and guides their transport across actin filaments to facilitate secretion of
their contents.
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Abstract
ROLE AND REGULATION OF MYOSIN IIA IN NATURAL KILLER CELL
CYTOTOXICITY
Keri Sanborn
Advisor: Dr. Jordan S. Orange

Natural killer (NK) cells are lymphocytes of the innate immune system that provide
defense by directing their cytotoxic activity against virally infected and tumorigenic cells.
Target cell lysis requires directed secretion of lytic granule contents, including poreforming perforin and apoptosis-inducing granzymes, at the contact site. During the
formation of a mature immunological synapse (IS) with a target cell, an NK cell
polymerizes filamentous actin (F-actin) at the contact site, which may serve as a barrier
to secretion of lytic granules for cytotoxicity. An actin-based motor protein, nonmuscle
myosin IIA, has been demonstrated to be required for NK cell cytotoxic activity. In this
work, we examine the role of myosin IIA in NK cell cytotoxicity. Through studies of
primary human NK cells and NK cell lines, we find that myosin IIA associates with NK
cell lytic granules. This functional association is required for NK cell granule exocytosis
because myosin IIA mediates an interaction of lytic granules with F-actin at the IS. We
find that NK cell cytotoxicity is impaired in patients with mutations in the myosin IIA
heavy chain, and that mutations in the motor domain and nonhelical tailpiece specifically
affect NK cell function. Finally, we demonstrate that single molecules of myosin IIA
associate with NK cell lytic granules via the nonhelical tailpiece of the myosin IIA heavy
chain, and that this interaction requires phosphorylation of the tailpiece at Ser1943.
Thus, we present a novel role for nonmuscle myosin IIA in NK cells, where myosin IIA
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directly associates with lytic granules and guides their transport across actin filaments to
facilitate secretion of their contents.
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Chapter 1: Introduction1
Summary
Natural killer (NK) cells have an inherent ability to recognize and destroy a wide
array of cells rendered abnormal by stress or disease. NK cells can kill a targeted cell
by forming a tight interface rich in filamentous actin (F-actin) - the lytic immunological
synapse (IS). This represents a dynamic molecular arrangement that over time
progresses through a series of steps to ultimately deliver the contents of specialized
organelles known as lytic granules. In order to mediate cytotoxicity, the NK cell must
mobilize the lytic granules, polarize them to the targeted cell, facilitate their
approximation to the NK cell membrane, and release their contents. This thesis focuses
on the challenge of secreting NK cell lytic granules through the dense layer of F-actin at
the IS, and in particular the role of the actin motor protein nonmuscle myosin IIA in this
process.
Introduction: cell-mediated immunity
NK cells are the major lymphocytes of the innate immune system that provide critical
defense against cancerous and virally infected cells. NK cells are orchestrators of
immune responses, providing costimulation for other cells and producing cytokines such
as interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) (reviewed in
(Orange and Ballas, 2006)). The importance of NK cells in combating viruses and tumor
cells is revealed by the fact that patients with NK cell deficiencies are highly susceptible
to herpesviruses and certain types of cancers (Orange, 2006). While NK cell activation
1
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is important for defense against cancer and pathogens, over-activation of NK cells has
been connected to autoimmune and inflammatory diseases (Perricone et al., 2008), and
thus NK cell activity must be carefully regulated.
While their counterparts in the adaptive immune system, CD8+ T cells, utilize
recombination for the creation of antigen-specific activation receptors, NK cells are
instead activated by germline-encoded receptors for common intracellular antigens and
ligands upregulated on infected and cancerous cells (reviewed in (Biassoni, 2009) and
(Vivier et al., 2008)). Because they contain many diverse activation receptors, NK cells
also express a family of inhibitory receptors, which recognize self major
histocompatibility complex (MHC) proteins, to prevent NK cells from becoming activated
by normal cells. When the balance of activation and inhibition is tipped towards
activation, NK cells are activated to kill infected or cancerous target cells.
The most critical function of NK cells, as well as CD8+ T cells, during elimination of
infected or transformed target cells is lytic granule-mediated cytotoxicity. Lytic granules
are specialized organelles, a form of secretory lysosomes, containing the pore-forming
molecule perforin and cell death-promoting molecules such as granzymes (Kupfer et al.,
1991). It was initially thought that perforin created a pore in the outer cell membrane
that allowed granzymes to enter the target cell and activate the caspase cascade to
promote target cell apoptosis (Tschopp et al., 1986). Recent work, however, suggests a
different mechanism, where perforin polymerization on the target cell membrane causes
a brief influx of calcium into the target cell, which initiates clathrin-mediated endocytosis
of both perforin and granzymes as part of the membrane-repair response (Thiery et al.,
2010). Once perforin and granzymes are endocytosed together, perforin releases
granzymes from the large endosomes (or “gigantosomes”), and granzymes initiate cell
death. The importance of this process is highlighted by the susceptibility of perforin-
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deficient human patients and mice to viral infections and cancer (Kagi et al., 1994; Stepp
et al., 1999).
Steps leading to natural killer cell cytotoxicity
Upon recognizing target cells using their germline-encoded activation receptors, NK
cells promote host defense by lysing these cells via the secretion of lytic granule
contents. This process, termed directed secretion, begins with the formation of an
immunological synapse at the contact site between an NK cell and a target cell.
Adhesion and activation
NK cell activation takes place in a tightly regulated series of stages (Figure 1.1).
When an NK cell first encounters a potentially transformed or infected target cell,
receptors strengthening the interaction between the effector and target cells are ligated.
Selectins and integrins, such as L-selectin, LFA-1, and MAC-1, have been implicated in
the initial adhesion step, and are required for effective conjugation between NK cells and
their targets (Chen et al., 2005; Davis et al., 1999; Orange et al., 2003; Vyas et al.,
2001). This adhesion allows for activation receptors on the NK cell, such as natural
cytotoxicity receptors and activating killer cell immunoglobulin-like receptors (KIRs), to
focus in the direction of the target cell.

In NK cells, activation signaling can be

balanced by inhibitory signaling, often from inhibitory KIRs recognizing self MHC
molecules (Eissmann and Davis). If the balance of activation and inhibition leans
towards activation, the NK cell is activated to progress through further steps in maturing
a lytic interface with its target and thus initiate steps to kill the dangerous cell.
Immunological synapse formation and maturation
Following adhesion and activation signaling, the NK cell forms a tight interface with
the target cell, known as the immunological synapse (IS). This process is initially
mediated by members of the integrin family of adhesion molecules, which cluster at the
contact site and utilize a higher-affinity conformation to promote firm adhesion and

3

Figure 1.1. Steps to the formation of the NK cell IS.
When an NK cell contacts a target cell, adhesion and activation receptors are ligated, causing
the convergence of lytic granules to the MTOC (A, left). As signaling increases past an
activation threshold, the MTOC moves along with associated lytic granules toward the IS, and
actin polymerizes at the contact site (A, middle). Actin polymerization and lipid raft
polarization at the IS increases as the IS matures, and lytic granules reach the IS with the
MTOC (A, right). During the effector phase (B), lytic granules exhibit myosin IIA-mediated
motility toward an area of actin hypodensity, but not absence (left), and granule contents,
including perforin and granzymes, are secreted at the IS to effect target cell lysis (right).
When the target cell initiates apoptosis, the NK cell detaches and recycles granule membrane,
preparing to lyse another target (C).
Figure adapted from Orange JS, “Formation and function of the lytic NK-cell immunological
synapse,” Nature Reviews Immunology, September 2008

adhesion signaling (Barber et al., 2004; Davis et al., 1999; Orange et al., 2003; Vyas et
al., 2001). The IS is the site of actin polymerization and reorganization (Carpen et al.,
1983), which require the activity of guanine exchange factor Vav1 to transmit activation
signals, as well as actin nucleation by Arp2/3, WASp, and WAVE2 and stabilization of
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nascent filaments by HS1 (Barber et al., 2004; Butler et al., 2008; Graham et al., 2006;
Orange et al., 2002; Orange et al., 2011). Actin polymerization at the IS improves the
stability of the contact by allowing the NK cell to undergo shape changes to closely hug
the target cell (Orange et al., 2003; Wulfing et al., 2003). Without the ability to
reorganize F-actin, NK cells are not able to focus receptors and lipid rafts to the interface
or polarize lytic granules toward the IS for secretion (Butler and Cooper, 2009; Graham
et al., 2006; Masilamani et al., 2006; Orange et al., 2003; Wulfing et al., 2003), which
suggests that F-actin polymerization at the IS represents an early step in the process of
cytotoxicity. Once F-actin polymerization at the IS begins, the contact site organizes into
several discrete zones, including a ring of F-actin and integrins at the periphery, known
as the peripheral supramolecular activation cluster (pSMAC), and a cluster of critical
signaling molecules at the central region of the interface, known as the central
supramolecular activation cluster (cSMAC). While in T cells, it is known that
microclusters of T cell receptor (TCR) signaling complexes move from the pSMAC to the
cSMAC during signal propagation (Varma et al., 2006), microclusters have only begun to
be examined in NK cells (Treanor et al., 2006). Additionally, the cSMAC may be more
important for downregulation of signaling, as TCR microclusters are ubiquitinized and
degraded during activation (Vardhana et al., 2010). Although the purpose of
organization into the pSMAC and cSMAC is debated and likely differs between cell
types, proper organization of the synapse is thought to be required for directed secretion
of lytic granules in NK cells (Bryceson et al., 2005; Stinchcombe et al., 2001b).
Commitment to target cell lysis: Movement of granules and the MTOC
Once an organized IS is formed, adhesion and activation signaling are further
amplified, finally reaching an activation threshold which directs the NK cell to commit to
secreting lytic granule contents. In order for this form of directed secretion to occur, the
microtubule organizing center (MTOC) and lytic granules must polarize to the IS.
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Movement of the MTOC to the IS is known to depend upon Lck, ERK, Vav1, Pyk2, and
hDia1 and Lck signaling (Butler and Cooper, 2009; Chen et al., 2006; Graham et al.,
2006; Sancho et al., 2000; Tsun et al., 2011), and stabilization of the MTOC and at the
IS depends upon CIP4 (Banerjee et al., 2007), but details of this movement are still
unclear. One important signal for granule polarization to the IS in NK cells appears to be
integrin signaling, as isolated ICAM-1 signaling through LFA-1 can induce granule
polarization (Bryceson et al., 2005), although in T cells integrin signaling may not be
necessary (Beal et al., 2009). In T cells, the movement of lytic granules and the MTOC
to the IS is thought to occur in two possible ways, which are dependent upon strength of
signal (Beal et al., 2009; Jenkins et al., 2009). When a strong signal is received, lytic
granules are delivered quickly to the IS in a focused manner, but when altered peptide
ligands for the T cell receptor are used experimentally, polarization is less focused.
Whether NK cells use these methods of granule delivery to the IS remains unknown,
however, evidence from our laboratory defines a rapid approximation of lytic granules to
the MTOC prior to their delivery to the IS (Mentlik et al., 2010). When an NK cell
contacts a potentially dangerous target cell, initial adhesion signaling through integrins,
independent of activation signaling, induces lytic granule convergence along
microtubules to the MTOC as an initial preparatory step for NK cell cytotoxicity. If
activation signaling occurs, the MTOC polarizes towards the target cell along with lytic
granules to allow lytic granule contents to be secreted. If the interaction is inhibitory,
however, no MTOC polarization occurs and the target cell is not killed. In this work, the
movement of lytic granules along microtubules was shown to be dynein-dependent, thus
demonstrating dynein as a minus-ended microtubule motor for lytic granules, suggesting
that dynein directly moves the granules along microtubules toward the MTOC (Mentlik et
al., 2010). The lysosomal sorting protein AP3 is also required for granule movement to
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the IS (Clark et al., 2003), likely due to a role in sorting a protein required for movement
rather than a direct motor function.
Lytic granule approximation to the membrane and accessing cytotoxicity from the
membrane-approximated granule
Once NK cell lytic granules gain access to the plasma membrane, they must fuse
with the membrane to allow for the secretion of their contents. This appears to be a
multi-step process, involving tethering, vesicle priming, and membrane fusion. In CTLs,
the small GTPase rab27a has been shown to link lytic granules as cargo to their target
membranes (Stinchcombe et al., 2001a). This tethering step appears to be necessary
for granule approximation to the plasma membrane. Once granules are tethered to the
membrane, they must be prepared for fusion. Munc13-4, a binding partner of rab27a,
has a critical role in vesicle priming for lytic granule exocytosis in CTLs and mast cells
(Neeft et al., 2005), and although levels of Munc13-4 are reduced in NK cells compared
to T cells (Neeft et al., 2005), the protein has been shown to interact with rab27a in NK
cells as well (Menager et al., 2007). Fusion of lytic granules with the membrane is
regulated by soluble N-ethylmaleimide-sensitive protein attachment protein receptor
(SNARE) proteins, which target granules to the correct portion of the membrane for
fusion. SNARE-related proteins required for NK cell cytotoxicity include VAMP7, which
associates with lytic granules (Marcet-Palacios et al., 2008), as well as syntaxin-11 and
Munc18-2, which interact with each other to drive membrane fusion for lytic granule
exocytosis in NK cells (Arneson et al., 2007; Bryceson et al., 2007; Cote et al., 2009).
These proteins are defective in a series of human diseases resulting from impaired
degranulation (reviewed in (Orange, 2008)). The proteins which mediate granule
tethering, priming, and membrane fusion may be differentially recruited depending on
strength or type of activation signal, serving as an additional layer of regulation for the
process of exocytosis (Liu et al., 2009).
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Once lytic granules fuse with the plasma membrane, their membrane may need to
contract in order to facilitate the secretion of their contents. This process has been
shown in CD8+ T cells to involve acid sphingomyelinase (ASMase), an enzyme which
alters the composition of the membrane, forming ceramide, which curves the membrane
to cause contraction (Herz et al., 2009). Although it is not yet clear whether ASMase is
important in NK cells, it is likely that a similar mechanism occurs to direct NK cell granule
exocytosis. Once the lytic granules have contracted to release their contents, perforin
and granzymes work together to effect the lysis of target cells (discussed earlier and
reviewed extensively in (Hoves et al., 2009)). This process occurs in and is likely
facilitated by a cleft formed between the NK cell and target cell, which likely serves the
function of focusing these elements to the targeted cell (McCann et al., 2003). Following
the secretion of granule contents, granule membrane proteins are internalized in a
recycling process, allowing NK cells to create new lytic granules, thus recharging the
cytotoxic capacity for serial killing of targets (Liu et al., 2009).
Steps following lytic granule polarization toward the immunological synapse
Although lytic granules approximate the membrane by association with the MTOC,
there may be additional obstacles for polarized granules to overcome prior to priming,
docking, and fusion with the plasma membrane. In activated NK cells, the F-actin cortex
at the IS is dense and may present a barrier to secretion. Several questions remain
regarding this step of directed secretion: How do NK cell lytic granules reach the plasma
membrane upon arriving at the IS? How is F-actin cleared away for secretion and is this
a necessary component for secretion? If so, are the clearances sufficient for granule
fusion with the membrane, or are additional motor molecules required? Several recent
findings have begun to mold our understanding of this part of the process and provide
pieces to the complex puzzle of lytic granule exocytosis.
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Figure 1.2. Two models of lytic granule access to the plasma membrane during
cytotoxicity.
If a central clearance in actin forms when an NK cell contacts a target cell (A), lytic
granules can access the plasma membrane upon polarization to the IS. If, instead, actin
is not completely cleared from the contact site (B), actin acts as a barrier to secretion of
lytic granule contents.

Actin as a barrier to directed secretion
Once lytic granules are delivered to the IS by the microtubule network, they
encounter a dense F-actin cortex. An effective activating IS in NK cells requires
extensive actin polymerization, and without this polymerization, the MTOC and lytic
granules do not polarize in the direction of the target cell (Graham et al., 2006; Orange
et al., 2003; Wulfing et al., 2003). Proteins like Arp2/3, WASp, and HS1 help to promote
actin-mediated signaling through branching of the F-actin network, resulting in a
meshwork of actin filaments at the IS (reviewed in (Burkhardt et al., 2008; Orange,
2008)). Although precise measurements of the actin gathered at the IS have not been
performed, fluorescent images indicate that this layer of actin is dense (Huang et al.,
2005; McCann et al., 2003; Orange et al., 2003). This amount of actin could act as a
substantial physical barrier to the secretion of lytic granule contents (Figure 1.2).
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Granules may therefore require a combination of actin clearance mechanisms and
additional, F-actin-based, motor molecules to reach the plasma membrane.
Mechanisms of lytic granule access to the synaptic plasma membrane
One potential mechanism for allowing granules access to the membrane is the
creation of large clearances in F-actin (Figure 1.2A). Similar to T cells, F-actin
clearances in the cSMAC region of the IS have been reported in NK cells (Andzelm et
al., 2007; Orange et al., 2003; Roda-Navarro et al., 2004; Vyas et al., 2001). While the
formation of the actin clearance is known to be independent of microtubule integrity and
MTOC polarization (Orange et al., 2003), it has not yet been shown whether actin
hypodensity in the cSMAC occurs as a result of symmetrical actin reorganization in the
pSMAC region, or if the clearances are actively created by bundling or depolymerizing
actin filaments in the cSMAC. While several proteins, including the actin-associating
protein HS1 and the activation receptor NKG2D, have been implicated in IS symmetry
during cell spreading (Butler et al., 2008; Culley et al., 2009), in cells with perturbed actin
dynamics, a central clearance is typically still evident. Additionally, it remains unknown
whether any clearance in F-actin is long-lasting, or simply a transient effect during initial
NK cell:target cell conjugation.
Recent data demonstrate that lytic granules reach the IS through travel with the
MTOC (Mentlik et al., 2010; Stinchcombe et al., 2006). While there is evidence that
granules reach the plasma membrane in T cells via their association with the MTOC,
and do not require any additional form of microtubule-based or actin-based transport
(Stinchcombe et al., 2006), it remains unclear whether all lytic granule transport to the IS
from the MTOC is a feature of intimate MTOC approximation to the IS and independent
of non-MTOC-associated motor molecules. Lytic granule transport in NK cells has been
shown to be capable of occurring in the direction of microtubule plus-ends using the
microtubule motor kinesin (Burkhardt et al., 1993), and has been shown to require the
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actin motor myosin IIA ((Andzelm et al., 2007) and Chapters 2 & 3), suggesting that NK
cell degranulation may require motor molecules following polarization of granules to the
IS.
The role of myosin IIA in NK cell lytic granule exocytosis
Recently, a role for the actin motor protein myosin IIA has been shown in NK cell
cytotoxicity ((Andzelm et al., 2007) and Chapters 2 & 3 of this thesis). The mechanism of
this role for myosin IIA in NK cell cytotoxicity, and particularly in directing granule
transport across F-actin at the IS, is the main focus of this thesis.
Introduction to the myosin superfamily
The myosin superfamily is a diverse group of actin-based molecular motors. There
are at least eighteen different classes of myosin (Berg et al., 2001; Foth et al., 2006), as
defined by the ability to either translocate actin filaments or translocate cargo across
actin filaments (Sellers, 1999). All members of the myosin superfamily are able to
reversibly bind actin and hydrolyze MgATP, which allows them to use ATP hydrolysis as
an energy source for their movement along actin filaments. In many types of myosin,
MgATP hydrolysis is regulated by either phosphorylation or the presence of calcium ions
(Sellers, 1999).
Although the specific mechanisms of their actin motor function differ by class, all
myosins have a general structure in common. The head domain, which is typically at the
N-terminus and is comprised of 720-830 amino acids, is the globular domain which is the
site of actin binding and MgATP hydrolysis. This motor domain is mostly conserved
between myosin classes, particularly in the actin- and nucleotide-binding sites (Cope et
al., 1996; Goodson and Spudich, 1993). The neck region is a long α-helical region that
generally regulates myosin motor function through the association of light chains or
calmodulin (Sellers, 2000). The tail, which is the least conserved portion of myosin,
typically consists of an α-helical rod and nonhelical portion, and is critical for anchoring
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myosin to enable movement along filaments (Sellers, 1999). In myosin II, the tail is also
important for self-association into filaments ((Franke et al., 2005), reviewed in (Eddinger
and Meer, 2007; Ricketson et al., 2010)). Other structural aspects, including neck and
tail length, as well as the number of heads in each molecule, differ between myosin
classes.
The structure of myosin molecules is designed to couple ATP hydrolysis to
conformational changes which generate myosin motor function (Alberts, 2002). When a
myosin molecule, bound by its tail region to either cargo or other myosin molecules,
interacts with an actin filament, it binds along the side of the filament in a rigor
conformation, with the head tightly locked to the actin filament. When ATP binds to the
myosin head, a conformational change causes myosin to dissociate from the actin
filament. ATP hydrolysis causes a larger conformation change, where the myosin head
rotates, re-binding to actin at a position further along the filament. Release of the
phosphate group following hydrolysis allows for myosin to bind more tightly to the actin
filament, generating force in what is known as the “power stroke.” This force can either
translocate actin filaments, if the myosin tail is bound to a stationary object, or move
cargo along the actin filament, if the myosin tail is bound to a vesicle or small cargo.
Although the subclasses of myosin differ in structure, all move along the actin filament in
the direction of the plus end, with the exception of myosin VI, which is a minus end
directed actin motor (Menetrey et al., 2005; Wells et al., 1999).
The myosin superfamily is separated into subclasses by two different classifications.
First, the term “conventional myosins” is used to describe myosin II family members, as
these were first described in their role in muscle contraction, while all other myosin
classes are considered “unconventional myosins.” Second, myosins can also be
described by the location in which they function most often; thus, there are skeletal
muscle myosins, smooth muscle myosins, and nonmuscle myosins (Sellers, 1999).
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This thesis focuses specifically on the role of nonmuscle myosin IIA, and therefore
while other types of myosin may be important in the activities examined, only myosin IIA
will be discussed in detail.
Nonmuscle myosin IIA
Nonmuscle myosin II proteins are heterohexameric proteins consisting of two heavy
chains, two essential light chains, and two regulatory light chains (Figure 1.3). Like most
myosin classes, myosin II molecules have an N-terminal globular head region which is
important for F-actin binding and ATP hydrolysis. The neck region immediately following
the head contains the binding sites for the light chains, while the S2 region following the
neck is important for enabling the motion of the myosin head domain (Eddinger and
Meer, 2007). The C-terminal tail of myosin II molecules consists of a long α-helical
coiled-coil rod domain, followed by a small, globular nonhelical tailpiece. The rod
domain of myosin II is important for self-association into filaments (Ricketson et al.,
2010), while the nonhelical tailpiece regulates filament assembly and cargo binding, and

Figure 1.3. Structure of nonmuscle myosin IIA.
Myosin IIA is a heterohexameric protein consisting of two heavy chains (orange/yellow) and
four light chains (green). The N-terminus, or head, region, is important for actin binding and
ATP hydrolysis, while flexibility of the neck region is important to enable motor function. The
rod region consists of a coiled-coil of two α-helices and is important for filament formation,
while the C-terminal non-helical tailpiece is critical for cargo binding and can also regulate
filament formation.
Figure adapted from Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, Molecular
th
Biology of the Cell, 4 Edition. New York: Garland Science, 2002. p.950
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has been shown to be capable of directly binding to phospholipid membranes (Murakami
et al., 1994; Ricketson et al., 2010).
The nonmuscle myosin II family consists of three members: myosin IIA, myosin IIB,
and myosin IIC (Golomb et al., 2004; Shohet et al., 1989; Simons et al., 1991). The
three isoforms are extremely similar in head and S2 region sequences, as well as most
of the coiled-coil regions (64-80% sequence homology (Ronen and Ravid, 2009)). Their
tailpiece regions vary significantly, however, and it is the tailpiece that appears to target
each isoform to specific locations within the cell (Ronen and Ravid, 2009; Sandquist and
Means, 2008). The three isoforms are expressed variably in different tissues, and are
regulated differently as well. Myosin IIA is the main isoform expressed in hematopoietic
cells (Kawamoto and Adelstein, 1991), and as such will be the focus of the remainder of
the thesis.
The myosin IIA heavy chain, encoded by the gene MYH9 in humans, encodes a 227
kDa peptide. Its N-terminal head region ends at residue Lys835, transitioning into a
coiled-coil rod consisting of an S2 region (the first third of the rod) and a light
meromyosin region (through residue Pro1927). Following the rod domain is a nonhelical
tailpiece from Phe1928 to Glu1960 (Kopp, 2010; Kunishima et al., 2001a). As it is a
widely expressed protein, the roles for myosin IIA are constantly increasing, and new
mechanisms for its function are still being uncovered. Thus far, roles for myosin IIA
have been demonstrated in cell polarity and division, adhesion and migration, and
secretion, all of which will be discussed in later sections.
Regulation and inhibition of myosin IIA
Regulation of myosin IIA primarily occurs through phosphorylation of the heavy and
light chains. The regulatory light chains are phosphorylated at residues Ser19 (and
sometimes Thr18) by myosin light chain kinase (MLCK), Rho kinase (ROCK), protein
kinase C (PKC), p21 kinase, and AMP-activated protein kinase, which has been shown
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to regulate myosin motor function by increasing ATPase activity and promoting myosin
filament formation (Adelstein and Conti, 1975; Amano et al., 1996; Bresnick, 1999).
Phosphorylation at these sites is downregulated by myosin phosphatase (MYPT), which
dephosphorylates myosin light chains. Phosphorylation of the regulatory light chains
also occurs at Ser1/2 and Thr9, which is attributed to PKC. Phosphorylation by PKC
inhibits the ATPase activity of myosin IIA by decreasing its affinity for actin and inhibiting
MLCK phosphorylation of the light chains (Nishikawa et al., 1984).
Although the myosin IIA heavy chain contains 1960 amino acids and there are 42
serine, 17 threonine, and 9 tyrosine residues that are identified by NetPhos to be
predicted candidates for phosphorylation, phosphorylation of myosin IIA has been
demonstrated to occur at very few residues. PKC phosphorylates Ser1916 (in humans;
1917 in some species) near the end of the coiled-coil rod domain (Conti et al., 1991),
while casein kinase II phosphorylates Ser1943 (sometimes Ser1944) in the nonhelical
tailpiece (Murakami et al., 1998). Ser1916 phosphorylation has been demonstrated in
human platelets (Conti et al., 1991), and has also been shown to be important in mast
cell degranulation ((Ludowyke et al., 2006; Ludowyke et al., 1989; Ludowyke et al.,
1996), discussed later). This residue is also phosphorylated in the Jurkat human CD4+ T
cell line following treatment with phorbol 12-myristate 13-acetate (PMA), while Ser1943
is constitutively phosphorylated in Jurkat cells (Moussavi et al., 1993). Ser1943
phosphorylation is also important in regulating chemotaxis in breast cancer cells
(Dulyaninova et al., 2007). Thr1939 (sometimes Thr1940) phosphorylation has also
been demonstrated in some systems (Buxton and Adelstein, 2000; Ludowyke et al.,
1989), and does have a role in T cell migration (Jacobelli et al., 2004), however,
regulation at this residue is less common.
An additional mechanism of regulating myosin IIA is via interactions with other
proteins. One major binding partner for myosin IIA is the metastasis-associated protein
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1, or mts1. Mts1, also known as S100A4, was originally named for the correlation of
high levels of expression with metastatic potential of tumor cells, however, it is also
expressed at lower levels in normal cells. In the presence of calcium, Mts1 binds to
myosin IIA between residues 1909 and 1924 of the heavy chain (Kriajevska et al., 1998;
Li et al., 2003), and can depolymerize myosin filaments (Ford et al., 1997) and sequester
single myosin molecules, preventing formation of new filaments (Li et al., 2003;
Malashkevich et al., 2008). Mts1 binding also regulates the phosphorylation status of
myosin IIA heavy chains by inhibiting PKC phosphorylation of Ser1916, and therefore
can regulate filament formation in many ways (Kriajevska et al., 1998). Interestingly,
while PKC phosphorylation (at Ser1916, within the mts1 binding site) does not affect
mts1 binding, a study by Dulyaninova, et al. demonstrates that CKII phosphorylation (at
Ser1943, outside the binding site) protects against mts1 binding to the myosin IIA heavy
chain (Dulyaninova et al., 2005). While the mechanism for this is not yet clear, the
authors speculate that phosphorylation at Ser1943 causes the tailpiece of myosin IIA to
fold back onto the rod, blocking the binding site for mts1 (discussed further in Chapter 3
of this thesis).
Although many attempts to understand the role of a specific protein begin with the
construction of a mouse with a deletion in the gene of interest, a “knockout” of MYH9 is
lethal at day 6.5 of embryonic development (Conti et al., 2004). Therefore, many studies
have relied upon inhibitors of the myosin II motor function to elucidate the role of myosin
IIA in certain systems. One of the earliest inhibitors used was 2,3-Butanedione
monoxime (BDM), which was initially assumed to inhibit all myosin II ATPase activity but
was later shown to inhibit only skeletal muscle myosin II (Ostap, 2002). The MLCK
inhibitors ML-7 and ML-9 were used to inhibit myosin II ATPase activity by blocking
phosphorylation of the regulatory light chain (Saitoh et al., 1987). These inhibitors are
not considered to be specific myosin II inhibitors, however, as MLCK phosphorylates
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proteins other than the myosin II light chains, and the inhibitors themselves have offtarget effects as well (Bain et al., 2003; Bain et al., 2007). The most specific inhibitor
currently used is blebbistatin (Straight et al., 2003), a small molecule inhibitor which
binds to myosin II when its nucleotide binding cleft contains ADP and phosphate,
slowing release of the phosphate molecule and therefore blocking myosin in a
conformation with low affinity for actin (Allingham et al., 2005; Kovacs et al., 2004).
Although all inhibitors have some off-target effects, blebbistatin has been shown to
inhibit smooth muscle and nonmuscle myosin II without inhibiting class I, V, and X
myosins (Limouze et al., 2004). There are some limitations to use of the inhibitor,
however, as blebbistatin is both photoinactivated and phototoxic when illuminated by
wavelengths of light below 488 nm, making it impractical for use in some imaging
experiments (Kolega, 2004; Sakamoto et al., 2005). Therefore, ML-7 and ML-9 are still
used in some experiments requiring the use of GFP or blue light. Due to conservation of
the head domain and ATPase activity between myosin II isoforms, all myosin II inhibitors
will inhibit myosin IIA, IIB, and IIC. While this is not a concern in some cell types due to
the expression of only one isoform of myosin II, in others, siRNA is the best method of
specifically inhibiting the function of one isoform without disrupting the others.
Roles for myosin IIA in cell polarity and division
Perhaps one of the most well-defined roles of myosin IIA is in cell polarity and
division. Remodeling of the actin cytoskeleton is critical for the maintenance of cell
polarity, and myosin is often used by cells to generate the force necessary to translocate
bundled actin filaments. In epithelial cells, the ability of myosin IIA to drive contraction is
important for the stability of cell-cell junctions and for contact inhibition (CarmonaFontaine et al., 2008; Yamada and Nelson, 2007). Myosin IIA-mediated contractility is
also important in the response to substrate stiffness and mechanical cues, which direct
cell polarity and development (reviewed in (Clark et al., 2007)). Additional roles for
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myosin II exist in directing the positioning of the mitotic spindle and cleavage furrow in
dividing cells, where the balance of myosin activity on each side of a dividing cell
determines whether a cell divides symmetrically or asymmetrically (Ou et al., 2010;
Weber et al., 2000). Because cell polarization during division is critical for differentiation,
myosin II activity has been shown to be required for embryogenesis and development
(reviewed in (Conti and Adelstein, 2008)). While a complete discussion of the roles of
myosin II in cytokinesis is beyond the scope of this thesis, the topic has been the subject
of recent reviews (Burgess, 2005; Matsumura, 2005).
Roles for myosin IIA in cell migration and adhesion
Myosin IIA is an important regulator of cell migration due to its role in adhesion and
cell polarity (Vicente-Manzanares et al., 2009). Cell migration is characterized by the
formation of new adhesions and remodeling of the actin cytoskeleton to generate
movement. A migrating cell typically has two actin-containing structures at the leading
edge of the cell, the lamellipodium and the lamellum. Branched actin polymerization
driven by Arp2/3 generates the lamellipodium at the leading edge, while thicker bundles
of actin filaments form the adjacent lamellum (Pollard and Borisy, 2003). Although
retrograde flow of actin occurs in both zones, the flow is slower in the lamellum. At the
area of convergence between the lamellipodium and the lamellum, actin reorganization
is critical for generation of movement in the cell (Ponti et al., 2004). Myosin II has been
proposed to have a role in generation of retrograde actin flow in the lamellum, as
inhibition of myosin II with blebbistatin decreases the rate of actin flow there (Cai et al.,
2006; Medeiros et al., 2006; Ponti et al., 2004). While inhibiting myosin II increases
protrusiveness in the cell, this does not mean the role of myosin in migration is inhibitory;
myosin II-mediated remodeling of actin in the lamellum can serve to control the motion of
the cell, allowing the cell to migrate in a directed fashion. Additionally, myosin II activity
is required for the maturation of nascent adhesions in the lamellipodium, perhaps due to
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its ability to stabilize actin filament bundles and therefore cluster important adhesion
proteins (Choi et al., 2008; Humphries et al., 2007), or more directly due to its role in
activating adhesion proteins (del Rio et al., 2009; Friedland et al., 2009). At the same
time, in the trailing edge of a migrating cell, myosin II activity is responsible for breaking
adhesions and disassembling the actin network, therefore mediating retraction of the
trailing edge (Chrzanowska-Wodnicka and Burridge, 1996; Wilson et al., 2010). Myosin
II is also important for the response to mechanical cues from the environment, and
therefore has a role in determining the direction of migration (reviewed in (Clark et al.,
2007)). The roles of different myosin II isoforms in cell migration vary, as the isoforms
are differentially regulated ((Betapudi, 2010; Sandquist and Means, 2008), reviewed in
(Conti and Adelstein, 2008)).
Recently, a role for myosin IIA has been characterized in T cell migration (Ilani et al.,
2009; Jacobelli et al., 2009; Jacobelli et al., 2004; Jacobelli et al., 2010). When
performing immune surveillance, a migrating T cell holds a characteristic “hand-mirror”
shape, consisting of leading edge protrusions and a smaller trailing edge, also called a
uropod ((McFarland and Heilman, 1965), reviewed in (Burkhardt et al., 2008)). When T
cells encounter their cognate antigen, they stop migrating, round up, and form an
immunological synapse with the antigen-presenting cell, or APC (Negulescu et al.,
1996). In migrating T cells, myosin IIA is enriched in the uropod (Jacobelli et al., 2004),
where it associates with the integrin LFA-1 (Morin et al., 2008). The interaction of
myosin IIA with LFA-1 helps to mediate the de-adhesion of LFA-1 on ICAM-1 substrates,
allowing for retraction of the uropod. Crawling T cells treated with myosin II inhibitors or
myosin IIA siRNA do not migrate properly, either becoming entirely non-motile (Jacobelli
et al., 2004) or becoming consistently more elongated, if they are migrating across LFA1 ligands (Morin et al., 2008). This interaction between myosin IIA and LFA-1 may be
more complex, however, as more recent reports suggest that they mediate two
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independent modes of migration in T cells, with myosin IIA controlling faster, “amoeboid”
motility and LFA-1 directing a “sliding” motility dependent on a single moving adhesion
(Jacobelli et al., 2009; Jacobelli et al., 2010). When T cells stop migrating and form a
contact with an APC, myosin IIA relocalizes from the uropod to the IS, a process which
is mediated by phosphorylation of Thr1939 of the myosin IIA heavy chain (Jacobelli et
al., 2004). While ATPase activity isn’t required for the accumulation of myosin IIA at the
IS, and IS formation occurs independently of myosin IIA, myosin IIA is necessary for T
cell signaling downstream of Lck, and therefore for stability of the IS during T cell
activation (Ilani et al., 2009; Jacobelli et al., 2004). Whether this role for myosin IIA is
unique to T cells or similar in NK cells remains to be determined; while IS formation is
intact in NK cells following myosin IIA inhibition or silencing (Andzelm et al., 2007), the
role of myosin IIA in NK cell migration has not yet been examined.
Roles for myosin IIA in organelle transport and secretion
A less well-defined role for myosin IIA exists in organelle transport and directed
secretion. While inhibition of myosin II reduces directed secretion in several systems
(discussed below), the specific role for myosin in secretion appears to be variable. In
recent years, two main options for the mechanism of myosin function in secretion have
emerged: indirect promotion of secretion through cytoskeleton reorganization, and direct
facilitation of organelle transport.
In some cell types, myosin II appears to have a more indirect role in secretion,
namely in facilitating the creation, expansion, or maintenance of clearances in F-actin to
allow for vesicle secretion. This mechanism has been demonstrated in cortical granule
exocytosis in zebrafish eggs, where myosin II is involved in remodeling the cytoskeleton
around areas of secretion (Becker and Hart, 1999). Myosin II activity is also required for
the expansion and maintenance of fusion pores in chromaffin cells, which allows for the
secretion of catecholamine in these cells (Berberian et al., 2009; Neco et al., 2008). A
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similar role has been described in pancreatic acinar cells, a specialized type of epithelial
cell that also requires a fusion pore for secretion (Bhat and Thorn, 2009). Myosin IIA
has also been described to have an indirect role in mast cell secretion. While
phosphorylation of myosin IIA occurs at the peak of degranulation in mast cells
(Ludowyke et al., 2006), and phosphatases PP1 and PP2A associate with myosin at the
same time (Holst et al., 2002), the authors of these studies speculate that the role for
myosin is in remodeling the cytoskeleton for granule secretion rather than in directly
guiding motility of mast cell granules. Actin remodeling is not directly evaluated in these
cells, however, and therefore the specific mechanism for myosin IIA in mast cell
secretion remains unclear.
In other systems, myosin II has been demonstrated to directly associate with the
organelles to be secreted, and to be involved in their secretion. Myosin II has been
shown to associate with vesicles derived from the Golgi (Fath, 2005; Ikonen et al.,
1997), and while its role in transport of these vesicles is debated (Ikonen et al., 1996;
Simon et al., 1998), some studies suggest that myosin IIA may be involved in the
transport of these vesicles from the Golgi to the plasma membrane ((Musch et al., 1997;
Stow et al., 1998), reviewed in (DePina and Langford, 1999)). Although myosin IIA is
thought to regulate the fusion pore in chromaffin cells (Berberian et al., 2009; Neco et
al., 2008), it may also direct vesicle transport in these cells (Neco et al., 2004). An
association of myosin II with secretory vesicles has been demonstrated in diverse cell
types, including human and bovine retinal pigmented epithelial cells (Linz-McGillem and
Alliegro, 2003), clam and frog oocytes (DePina et al., 2007; Yu and Bement, 2007), and
Drosophila neurons (Seabrooke et al., 2010). In the cases of clam oocyte extracts and
Drosophila neurons, inhibition of myosin II activity reduced the motility of vesicles, either
in vitro or in vivo. Although myosin IIA has not classically been known as a processive
motor for organelle transport (see below), the direct association of myosin IIA with
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vesicles for exocytosis and its role in their motility on actin filaments suggest an
unconventional role for myosin IIA in these systems.
Typically, organelle transport across actin filaments is thought to be mediated by
other myosins, such as myosins V and VI, which have well-characterized cargo binding
domains in the tail region and lever arms long enough to support processivity of the
motor over long stretches of actin. As a plus-ended actin motor, myosin V has important
roles in exocytosis in cells as diverse as neuroendocrine cells and melanocytes (Eichler
et al., 2006; Kural et al., 2007). Myosin VI, the only known minus end-directed actin
motor, is well known for its role in endocytosis (Altman et al., 2007; Buss et al., 2002;
Buss et al., 2004; Hasson, 2003). Although many systems rely on these motors for
transport, there are some systems in which other myosin isoforms can be used, even if
their conformation is less than ideal for organelle transport. Motor molecules, like
myosin II, that lack processivity over long distances can still direct motion over a
distance, provided that enough motors exist on the cargo that at least one is in contact
with the track at all times (Gross et al., 2007). In this way, myosin II molecules could be
used to direct organelle transport, at least over short distances. Furthermore, although
myosin II has always been characterized as a non-processive motor, recent data
suggest that myosin IIB is, in fact, processive over short distances (Norstrom et al.,
2010). Although the authors of this study indicate that this property is unlikely to exist in
myosin IIA, the possibility still exists that through a combination of motor cooperation
and short-distance processivity, myosin IIA could direct the transport of organelles for
secretion, as has been described in the above studies. Instances can be imagined in
which the bulk of the transport has been performed by microtubule motors, and only brief
transport is needed across actin filaments. In these cases, myosin IIA may be perfectly
suitable for this role.
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MYH9-related disease
Mutations in the gene encoding the nonmuscle myosin IIA heavy chain, MYH9,
cause an autosomal dominant platelet disorder now categorized as MYH9-related
disease (MYH9-RD). The disease was first described by Dr. Richard May in 1909 and
Dr. Robert Hegglin in 1945, and was therefore initially termed May-Hegglin Anomaly
(Hegglin, 1945; Saito and Kunishima, 2008). The disorder was first characterized by
giant platelets, thrombocytopenia, and leukocyte inclusions, also known as Döhle bodies
(Hegglin, 1945; May, 1909). Additional disorders were later described which were also
due to MYH9 mutation, including Sebastian, Fechtner, and Epstein syndromes (Seri et
al., 2003). The confusion in nomenclature arose from the fact that in addition to the
hematological symptoms above, certain MYH9 mutations can also cause variable nonhematologic complications, including glomerulonephritis, sensorineural deafness, and
presenile cataracts ((Heath et al., 2001; Seri et al., 2003); reviewed in (Savoia and
Balduini, 1993)). As genomic sequencing became standard for diagnosis, all of the
disorders arising from mutations in MYH9 were grouped together as MYH9-RD. The
platelet disorders evident in this disease arise from the role of myosin IIA in regulating
the migration and development of megakaryocytes (Chen et al., 2007; Eckly et al., 2009;
Leon et al., 2007; Pecci et al., 2009); mutant myosin molecules are unable to properly
regulate the production of proplatelets, resulting in macrothrombocytopenia (low
numbers of abnormally large platelets). While the reasons for the renal disease present
in some patients is less clear, myosin IIA is important for maintaining podocyte structure
and contractility, and therefore mutations in MYH9 may alter the filtration function of the
glomerulus (Arrondel et al., 2002; Ghiggeri et al., 2003; Sekine et al., 2010). The
mechanisms behind deafness and cataracts in MYH9-RD are, as of yet, poorly
understood.
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Although some controversy still exists about whether there is a correlation between
the position of the mutation and the symptoms of the disorder, there is now substantial
support for a genotype-phenotype correlation (Dong et al., 2005; Franke et al., 2005;
Kunishima et al., 2001b; Pecci et al., 2008). In particular, patients with mutations in the
head domain of myosin IIA are more likely to have severe macrothrombocytopenia,
nephritis, and deafness, while patients with mutations in the rod and tailpiece typically
have milder thrombocytopenia and do not exhibit non-hematological symptoms (Pecci et
al., 2008). Especially severe disease is seen in patients with mutations of Arg702, who
often present with deafness early in life and can progress to end-stage renal failure
during mid-life (Kunishima et al., 2007; Sekine et al., 2010).
While no immunodeficiency has been described in patients with MYH9-RD, myosin
IIA is the primary myosin II isoform expressed in hematopoietic cells (Marigo et al., 2004;
Maupin et al., 1994), and therefore mutations in MYH9 could have a greater effect on
blood cells than on other systems.
Requirement for myosin IIA function in NK cell cytotoxicity
Recent work in human NK cells has demonstrated a role for myosin IIA in NK cell
cytotoxicity (Andzelm et al., 2007; Krzewski et al., 2006). In primary human NK cells and
human NK cell lines treated with the myosin II inhibitor blebbistatin or siRNA against
myosin IIA (but not myosin IIB), cytotoxicity was significantly decreased (Andzelm et al.,
2007). Although NK cells without myosin IIA function were capable of conjugating with
target cells, polymerizing actin at the IS, and polarizing activation receptors, the MTOC,
and lytic granules to the IS, they were unable to degranulate (Andzelm et al., 2007).
Myosin IIA has also been shown to exist in a complex with actin and the actinremodeling proteins WIP and WASp at the IS in activated, but not inhibited, NK cells
(Krzewski et al., 2006). While this complex may be important for activation signaling, the
polarization of activation receptors and polymerization of actin at the IS are intact in NK
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cells following myosin inhibition (Andzelm et al., 2007), suggesting that myosin IIA may
have an alternative role in NK cell cytotoxicity. Examining the role of myosin IIA is the
goal of this thesis.
Thesis objectives
The overall objective of this thesis was to examine the role of myosin IIA in NK cell
degranulation and cytotoxicity, as well as the regulation of myosin IIA in this process. I
hypothesized that myosin IIA associates directly with NK cell lytic granules, mediating
their transport across F-actin at the IS to enable degranulation. As shown in Chapter 2,
we have found that myosin IIA is associated with NK cell lytic granules, and that the
motor function of myosin IIA is required for the ability of lytic granules to interact with Factin. The myosin IIA nonhelical tailpiece was identified as critical to the ability of
myosin to mediate the interaction of lytic granules with F-actin as well. In Chapter 3, we
examine the role of the tailpiece in regulating myosin IIA function on lytic granules. We
have found that there is a unique requirement for the head and tail regions of myosin IIA
in NK cell cytotoxicity, and that the rod domain is less required for the function of myosin
on lytic granules. Furthermore, constitutive phosphorylation of Ser1943 in the nonhelical
tailpiece of myosin IIA regulates the ability of myosin to interact productively with lytic
granules. Therefore, the tailpiece of myosin IIA is critical for granule transport across
actin for NK cell cytotoxicity due to the requirement for this phosphorylation site in
mediating the interaction of myosin IIA with lytic granules. Finally, in Chapter 4, I
examine the impact of these findings and discuss areas of future research.
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Chapter 2: Myosin IIA associates with NK cell lytic granules to
enable their interaction with F-actin2
Summary
NK cell cytotoxicity requires the formation of an actin-rich immunological synapse
(IS) with a target cell and the polarization of perforin-containing lytic granules toward the
IS. Following the polarization of lytic granules, they traverse through the actin-rich IS to
join the NK cell membrane in order for directed secretion of their contents to occur. We
examined the role of myosin IIA as a candidate for facilitating this pre-final step in lytic
NK cell IS function. Lytic granules in and derived from a human NK cell line, or ex vivo
human NK cells, were constitutively associated with myosin IIA. When isolated using
density gradients, myosin IIA-associated NK cell lytic granules directly bound to F-actin
and the interaction was sensitive to the presence of ATP under conditions of flow. In NK
cells from patients with a truncation mutation in myosin IIA, NK cell cytotoxicity, lytic
granule penetration into F-actin at the IS, and interaction of isolated granules with Factin were all decreased. Similarly, inhibition of myosin function also diminished the
penetration of lytic granules into F-actin at the IS, as well as the final approach of lytic
granules to and their dynamics at the IS. Thus, NK cell lytic granule-associated myosin
IIA enables their interaction with actin and final transit through the actin-rich IS to the
synaptic membrane, and can be defective in the context of naturally occurring human
myosin IIA mutation.
2

A version of this chapter has been published as:

Sanborn KB, Rak GD, Maru SY, Demers K, Difeo A, Martignetti JA, Betts MR, Favier R, Banerjee
PP, Orange JS.
Myosin IIA associates with NK cell lytic granules to enable their interaction with F-actin and
function at the immunological synapse.
The Journal of Immunology. June 2009; Vol. 182 pp.6969-84.
Copyright 2009. The American Association of Immunologists, Inc.
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Introduction
NK cells are lymphocytes of the innate immune system which are important for
defense against cancer and viral infection (reviewed in (Vivier et al., 2008)). NK cells
directly kill transformed and infected cells, and also provide costimulation and produce
cytokines to enhance immunity. Following NK cell conjugation with a target cell, an IS
forms at the contact site. The IS represents an arrangement of molecules that changes
over time to enable NK cell functions (Banerjee, 2008; Davis and Dustin, 2004; Orange,
2008). During NK cell cytotoxicity, the IS matures to consist of a peripheral ring of Factin and adhesion molecules surrounding a secretory domain containing lytic granules
(Stinchcombe et al., 2006). Upon initial adhesion to target cells, NK cell activation
causes polarization of the NK cell secretory machinery toward the target cell. Lytic
granules traffic to the IS via microtubules, and exocytosis of their contents, including
granzymes and perforin (Peters et al., 1991), at the plasma membrane is required for
cytotoxicity (Banerjee et al., 2007; Chen et al., 2006; Kopcow et al., 2005; Kupfer et al.,
1991; Orange et al., 2003). While discrete steps in cytotoxicity have been identified
following the movement of lytic granules to the IS with the MTOC, these primarily involve
docking and fusion with the cell membrane (Bryceson et al., 2007; Feldmann et al.,
2003; Menager et al., 2007). The F-actin cortex at the IS is dense, however, and
although the lytic granules may come very close to the membrane via microtubules, the
actin accumulated at the IS and bordering a secretory domain may nonetheless present
an obstacle to lytic granules reaching the membrane. Therefore, transit through the Factin-rich cell cortex may present an additional requirement for granule release prior to
membrane fusion.
Myosin superfamily members have been defined as important facilitators of
immunological function (Andzelm et al., 2007; Jacobelli et al., 2004; Ludowyke et al.,
2006). Myosins are ATP-dependent motors which generate force and movement along
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actin filaments and can facilitate cell motility and migration (Deng et al., 1999;
Geisbrecht and Montell, 2002; Jacobelli et al., 2004; Lee et al., 2004). Nonmuscle
myosin IIA, however, may have an additional role in NK cells, as it is present in a
heterogeneous protein complex formed in NK cells upon their conjugation with
susceptible target cells (Krzewski et al., 2006). Myosin IIA is a hexameric protein
consisting of two heavy chains, two regulatory light chains, and two essential light chains
(reviewed in (Sellers, 2000)). The N-terminal portion of the protein binds to actin and is
important for ATP-dependent motor function, while the C-terminal portion is involved in
filament formation and cargo binding (Cross and Vandekerckhove, 1986; Eddinger and
Meer, 2007; Ikebe et al., 2001; Nyitray et al., 1983; Sinard et al., 1990). Recently, a
requirement for myosin IIA in NK cell degranulation was defined (Andzelm et al., 2007).
Interference with myosin IIA function using the specific myosin II inhibitor blebbistatin
(Straight et al., 2003) or the myosin light chain kinase inhibitor ML-9 (Saitoh et al., 1987),
or myosin IIA small inhibitory RNA, decreased NK cell cytotoxic activity and exocytosis
of lytic granule contents, but did not alter effector-target conjugation or NK cell IS
formation (Andzelm et al., 2007). While myosin IIA has been implicated in the overall
process of NK cell cytotoxicity (Andzelm et al., 2007), it is unclear how it enables lytic
granule exocytosis.
Mutations in the heavy chain of myosin IIA, MYH9, cause several human
disorders, including May-Hegglin anomaly (Heath et al., 2001; Kelley et al., 2000; Seri et
al., 2000), characterized by macrothrombocytopenia and leukocyte inclusions.
Additional variable somatic abnormalities can occur depending upon the specific MYH9
mutation, however, previous studies of patients with these disorders have not pursued or
identified immunological deficiencies. Here, we define a deficiency of NK cell
cytotoxicity in four patients with May-Hegglin anomaly resulting from a C-terminal
truncation of MYH9 at position 1933 and have defined a potential mechanism by which
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myosin IIA enables NK cell lytic granule exocytosis. We demonstrate that myosin IIA
constitutively interacts with NK cell lytic granules and is required for the functional
interaction of lytic granules with F-actin as well as their final approach to the synaptic
membrane.

Results
Human NK cells with a myosin IIA 1933x mutation have reduced cytotoxicity and
lytic granule entry into F-actin at the IS
Inhibition of myosin IIA with blebbistatin or ML-9, or reduction of its expression using
siRNA was previously shown to block NK cell cytotoxicity but not lytic granule
polarization to the IS (Andzelm et al., 2007). Thus, we wanted to determine the role of
myosin IIA in enabling granule release following lytic granule polarization. To evaluate
an endogenous role for myosin IIA in human NK cells with a link to disease, we
assessed NK cell function in four May-Hegglin anomaly patients heterozygous for a
C5797T mutation in MYH9. This mutation introduces a stop codon leading to C-terminal
truncation of the myosin IIA heavy chain at position 1933 (1933x (Kelley et al., 2000;
Seri et al., 2000)). PBMCs from all four patients demonstrated significantly reduced
cytotoxic activity against K562 target cells when compared to control donors (Figure
2.1A,B). To determine that the reduction in cytotoxicity was not transient, one of the four
patients (patient 1) was evaluated longitudinally. In four independent assessments over
a period of twenty months, the mean cytotoxicity mediated by patient PBMCs was
reduced (data not shown). To ensure that the reduced cytotoxicity was not a feature of
other cells present in PBMC preparations, and to control for potential variability in the
percentage of NK cells, NK cells from three patients and controls were enriched by
negative selection and immediately evaluated in a cytotoxicity assay. The cytotoxic
activity of patient ex vivo NK (eNK) cells against K562 target cells was still reduced
compared to control eNK cells (Figure 2.1B,C). Since myosin IIA was previously shown
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Figure 2.1. Effect of myosin IIA 1933x mutation on cytotoxicity and perforin
localization at the IS.
(A) Cytotoxicity of control donor (blue) and myosin IIA 1933x patient (red) PBMCs against
51
K562 target cells. Mean ±SD specific K562 Cr-release from 3 separate control donors and
patients is shown. Individual experiments were performed in triplicate and averages of these
were used to calculate means of the patients or controls ± SD. (B) Mean K562 lytic units ±SD
of PBMCs and eNK cells from four control donors (black) and myosin IIA 1933x patients
(gray). Patient and control means were compared using the exact Wilcoxon-Mann-Whitney
test: **p=0.014 for PBMCs and *p=0.05 for eNK cells. (C) Cytotoxicity of control donor (blue)
and myosin IIA 1933x patient (red) eNK cells against K562 target cells. Mean ±SD specific
51
Cr-release from three separate control donors and patients is shown. (D) Flow cytometric
+
analysis depicting CD107a exposure in CD3 CD4 CD56 cells from control donor and myosin
IIA 1933x patient PBMC populations mixed with DMSO or K562 cells. Flow cytometry was
performed with the assistance of Korey Demers.

to be needed for NK cell degranulation as determined by CD107a upregulation (Andzelm
et al., 2007), we wanted to determine if the decreased cytotoxicity in patient NK cells
was due to a similar blockade. After incubation with K562 target cells, CD107a was
upregulated on control donor NK cells, but not on those from a patient (Figure 2.1D).
Thus, both cytotoxicity and degranulation are defective in patients with a myosin IIA
truncation, similar to blebbistatin or MYH9 siRNA-treated NK cells (Andzelm et al.,
2007).
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Figure 2.2. IS formation in NK cells with 1933x mutant myosin.
Confocal fluorescent micrographs of control donor (A,F), myosin IIA 1933X patient 1 and 3
(B,G), and blebbistatin-treated control (C) eNK cells conjugated with K562 target cells.
Differential interference contrast (DIC), actin (blue), wild-type myosin IIA (red), perforin
(green), and overlays are shown. Scale bar = 5 µm. Anti-myosin IIA antibodies were utilized
that recognize wild-type (A-C) or both mutant and wild-type forms (F-G). (D,H) Mean volume
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To examine the mechanism underlying defective cytotoxicity in 1933x patient NK
cells, we evaluated the localization of perforin, which is contained in lytic granules,
relative to F-actin and myosin IIA at the IS in patient eNK cells. Control donor and 1933x
patient eNK cells were conjugated to K562 target cells, fixed, and evaluated using
confocal microscopy. In eNK cells with perforin polarized toward the IS, volumes of
perforin, actin, and myosin IIA fluorescence were identified. In control eNK cells, there
was extensive colocalization between volumes of perforin and F-actin (Figure 2.2A,F
and Video 1A), suggesting the penetration of lytic granules into accumulated F-actin at
the IS. In contrast, in 1933x eNK cells (Figure 2.2B,G and Video 1B) and blebbistatintreated eNK cells (Figure 2.2C and Video 1C), perforin was polarized toward the IS
(quantified in Figure 2.3A), but there was substantially reduced colocalization between
volumes of perforin and F-actin at the IS compared to control (Figure 2.2E,I). This
suggests that myosin-IIA function was required for lytic granule penetration into F-actin
accumulated at the IS.
To begin to understand the role of myosin IIA in granule penetration into F-actin at
the IS, we evaluated myosin IIA localization in eNK cells using one of two different
antibodies. The first detected only wild-type myosin IIA, while the second detected both
truncated and wild-type forms. In control eNK cells, there was extensive colocalization
between perforin and myosin IIA (Figure 2.2A,D,E,F,H,I and Video 1D). In patient eNK
cells, colocalization between perforin and wild-type myosin IIA was reduced (Figure
2.2B,D,E; 6C,D; and Video 1E), but when total myosin IIA was considered, the

±SD occupied by actin (A), perforin (P), myosin IIA (M), or a combination is shown for control
(black), myosin IIA 1933X patient (gray), and blebbistatin-treated (white, D only) eNK cells
conjugated with K562 cells. (E, I) Mean percent colocalization ±SD among the fluorescent
volumes in control (black), myosin IIA 1933X patient (gray), and blebbistatin-treated (white, E
only) eNK cells conjugated with K562 cells. The percentage of myosin IIA colocalized with
perforin (M/P), perforin with myosin (P/M), perforin with actin (P/A), actin with perforin (A/P),
and actin with myosin and perforin (A/M/P) are shown. ≥10 cells per condition are
represented. Imaging and analysis were performed with the assistance of Pinaki Banerjee.
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colocalization of perforin with myosin IIA was similar to control (Figure 2.2G,H,I). This
suggests that although a normal amount of myosin IIA colocalized with perforin in patient
NK cells, its function was reduced by the inclusion of the mutant form. In blebbistatintreated eNK cells, however, the colocalization between perforin and myosin IIA was
slightly reduced compared to control (Figure 2.2C,D,E and Video 1F). Differences were
not a feature of protein present per unit volume, as the total mean intensity of fluorescent
regions was similar between the different eNK evaluated (Figure 2.3B). The quantity of
perforin and actin in cells and the quantity of F-actin accumulated at the IS was also
similar between control, 1933x, and blebbistatin-treated cells (Figure 2.3A-B,G),
suggesting that defective myosin IIA was not affecting these parameters. Thus, although
actin accumulated at and perforin polarized toward the IS, the colocalization between
perforin and F-actin in 1933x and blebbistatin-treated eNK cells was reduced relative to
control. This suggests decreased penetration of lytic granules into the F-actin cortex at
the IS in these cells and implies a role for myosin IIA in facilitating lytic granule
interaction with F-actin after they are polarized to the IS.
Myosin IIA is not required for IFN-γ secretion
Because myosin IIA was previously demonstrated to be necessary for exocytosis of
lytic granule contents (Andzelm et al., 2007), we wanted to determine whether it is a
general requirement for all types of secretion in NK cells. Thus, we measured IFNγ secretion, which is a differentially regulated process from degranulation in NK cells
(Vahlne et al., 2008). We initially used YTS NK cells because they require myosin IIA for
cytotoxicity and lytic granule release, similar to eNK cells (Andzelm et al., 2007). YTS
cells were treated with vehicle control or blebbistatin and incubated in the presence or
absence of 721.221 target cells. The secretion of IFN-γ into the supernatant was
determined by ELISA after 0, 4, or 22 hours of incubation. In the absence of 721.221
cells, there was minimal IFN-γ in both vehicle- and blebbistatin-treated cell cultures. In
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Figure 2.3. Analysis of function and protein localization in NK cells from myosin
IIA 1933x patients 1 & 3.
(A) Mean distance ±SD of perforin centroid to the immunological synapse is shown for the
conjugates analyzed in Figure 2.2D-E. (B) Mean voxel intensity ±SD of actin (A), perforin (P),
wild-type myosin IIA (M), or a combination is shown for the conjugates analyzed in Figure
2.2D-E. (C) Mean percent colocalization ±SD among the fluorescent volumes in control (black)
and myosin IIA 1933X patient 3 (gray) eNK cells conjugated with K562 cells. The percentage
of wild-type myosin colocalized with perforin (M/P), perforin with myosin (P/M), perforin with
actin (P/A), actin with perforin (A/P), and actin with myosin and perforin (A/M/P) are shown.
(D) Mean volume ±SD occupied by actin (A), perforin (P), wild-type myosin IIA (M), or a
combination is shown for control (black) and myosin IIA 1933X patient 3 (gray) eNK cells
conjugated with K562 cells. For (C-D), 10 cells are represented. (E) Flow cytometric analysis
of mean ±SD perforin content of blebbistatin-treated and control eNK cells from 3 independent
donors. (F) Mean volume ±SD of perforin fluorescence is shown for the conjugates analyzed
in Figure 2.2D-E. (G) Mean F-actin accumulation ±SD at the IS (area x intensity of F-actin
fluorescence) is shown for the conjugates described in Figure 2.2D-E. Analysis was
performed with the assistance of Pinaki Banerjee.
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the presence of 721.221 cells, however, IFN-γ secretion was augmented after 4 hours
and increased further after 24 hours of incubation. The amount of IFN-γ secreted by
blebbistatin-treated cells was similar to that secreted by vehicle-treated cells (Figure
2.4A). This result was extended to control donor eNK cells allowed to conjugate with
721.221 cells, where there was also no inhibition of IFN-γ secretion observed in
blebbistatin-treated relative to vehicle-treated cells (Figure 2.4B). This demonstrates
that myosin IIA is not required for cytokine secretion, and that it is not a generalized
requirement for secretory activity in NK cells.
Myosin IIA and perforin colocalize in NK cells before and throughout IS formation
Because the requirement for myosin IIA in secretion appears to be specific to NK cell
lytic granule contents, we wanted to more thoroughly evaluate the localization of myosin
IIA relative to lytic granules in NK cells. YTS cells expressing a myosin IIA-GFP fusion
protein (YTS-MyoIIA-GFP) were generated and compared to YTS cells expressing GFP
alone using fixed and live cell confocal microscopy. Both of these cell lines, as well as

Figure 2.4. Effect of inhibition of myosin IIA on NK cell IFN-γγ secretion.
(A) YTS cells incubated with DMSO vehicle control or blebbistatin for 30 min and then
incubated in the presence or absence of 721.221 target cells at a 2:1 effector to target cell
ratio for 0h (white), 4h (gray), or 22h (black). IFN-γ secreted into supernatant was measured
by ELISA. Values shown are the mean ±SD of six independent experiments, each performed
on a separate date. (B) IFN-γ secretion by vehicle- or blebbistatin-treated control donor eNK
cells incubated in the presence of 721.221 target cells at a 2:1 effector to target ratio for 22h.
In each experiment, the IFN-γ secreted by blebbistatin-treated eNK cells was normalized to
the control (which is shown as 100%) and the values shown are the mean ±SD of three
independent experiments, each performed on a separate date. ELISA was performed with the
assistance of Saumya Maru.
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parental YTS cells, expressed similar levels of endogenous myosin IIA (Figure 2.5A),
however, YTS-MyoIIA-GFP cells expressed the additional myosin IIA-GFP fusion
protein. The overexpression of myosin IIA in these cells did not alter their cytotoxic
function, as measured in 51Cr-release assays (Figure 2.5B,C).
Using these cells, we first determined the localization of myosin IIA and perforin
throughout their volumes when conjugated to K562 cells made susceptible to YTS cell
cytotoxicity by stable expression of CD86 (KT86 (Banerjee et al., 2007)). As myosin IIA
is abundant in NK cells, an analysis algorithm was used with an intensity threshold to
include only the most intense fluorescent signal for myosin IIA, GFP, and perforin.
Myosin IIA was cytoplasmic but demonstrated variations in intensity, as identified using
anti-myosin IIA antibody, in fixed conjugates from all three cell lines (Figure 2.6A-C). In
YTS-GFP cells, GFP was localized throughout the cells, while in YTS-MyoIIA-GFP cells,

Figure 2.5. Expression and function of myosin IIA and perforin in unconjugated
NK cells.
(A) Western blot of whole cell lysate from YTS, YTS-GFP, and YTS-Myosin IIA-GFP cells
depicting myosin IIA (blue) and GFP (red). (B-C) Mean cytotoxicity ±SD of YTS, YTS-GFP,
and YTS-Myosin IIA-GFP cell lines with 721.221 (B) and KT86 (C) target cells from three
independent experiments. The mean of three replicates within each experiment was used to
generate the value for a given experiment.
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the GFP resembled myosin IIA localization (Figure 2.6B-C), and the mean percent
colocalization between GFP and myosin IIA in YTS-MyoIIA-GFP cells was higher than in
YTS-GFP cells (Figure 2.7A). Thus, myosin IIA-GFP fusion protein but not GFP alone
recapitulated the localization of endogenous myosin IIA.
In all cell lines, myosin IIA colocalized with lytic granules, as 4-14% of the myosin IIA
volume colocalized with perforin, and 39-65% of perforin volume colocalized with myosin
IIA (Figure 2.7B). Thus, a small pool of myosin IIA localized in lytic granule regions, but
a large proportion of lytic granule regions colocalized with myosin IIA. A similar
colocalization between perforin and myosin IIA-GFP fusion protein, but not GFP alone,
was identified in YTS-MyoIIA-GFP and YTS-GFP cells, respectively (Figure 2.7A).
Thus, the localization of the myosin IIA-GFP fusion protein to lytic granule regions was
specific.
We next wanted to determine if the colocalization between myosin IIA and lytic
granules changed during NK cell activation and IS formation in living cells. YTS-MyoIIAGFP or YTS-GFP cells were loaded with Lysotracker Red dye to visualize the lytic
granules, added to environmental chambers containing KT86 target cells and imaged
every 15 seconds. After conjugation, the lytic granules in NK cells began to polarize
toward the target cell (Figure 2.6D,E). During this time, in YTS-MyoIIA-GFP cells, a
portion of the myosin IIA-GFP in the cell remained with the lytic granules and polarized
along with them toward the IS (Figure 2.6D and Video 2). Although lytic granules still
polarized to the IS in YTS-GFP cells, the GFP was not increased in the region of the lytic
granules (Figure 2.6E and Video 3). This dynamic localization of myosin IIA-GFP, but
not GFP alone, with lytic granule regions was best visualized using a GFP intensity
pseudocolor scale (Figure 2.6D,E bottom and Videos 2,3 bottom). To quantify this
colocalization, multiple conjugated and unconjugated YTS-MyoIIA-GFP cells were
compared, and only the most intense myosin IIA-GFP fluorescence was measured (>1.5
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Figure 2.6. Myosin IIA colocalization with lytic granules.
Colocalization is measured in fixed (A-C) and live (D-I) NK cells. (A-C) Cytolytic conjugates
between YTS (A) YTS-GFP (B), or YTS-Myosin IIA-GFP (C) cells and a KT86 target cell.
Differential interference contrast (DIC) and confocal fluorescent images for myosin IIA (blue),
GFP (green), GFP intensity (rainbow), perforin (red), and overlays of fluorescence are shown.
Inset panels in lower left corner show an enlargement of the area containing lytic granules. (D-
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SD above the mean fluorescence intensity). The colocalization of Lysotracker Red with
myosin IIA-GFP was similar in unconjugated (mean = 65±4%) and conjugated (mean =
77±10) cells with no specific trend toward an increase or decrease in colocalization
(Figure 2.6F). A similar consistent colocalization between cellular myosin IIA-GFP and
Lysotracker Red was identified (12±1 in unconjugated and 17±4 in conjugated cells)
(Figure 2.6G). Furthermore, the intensity of myosin IIA-GFP within Lysotracker Red
regions remained constant after conjugation (Figure 2.6H), suggesting that recruitment
of myosin IIA-GFP to lytic granules was unlikely. The colocalization between Lysotracker
Red and GFP in YTS-GFP cells was consistently lower than in YTS MyoIIA-GFP cells
(Figure 2.6I), thus demonstrating that the presence of myosin IIA in the GFP fusion
enabled its preferential and consistent colocalization with lytic granules.
Myosin IIA is associated with NK cell lytic granules
To biochemically determine if myosin IIA interacts with lytic granules, granules were
isolated from NK cells by density gradient separation and collected in seven equal
volume fractions. Myosin IIA was identified in the lytic granule preparation by Western
blot, and co-migrated with perforin, granzyme B, and LAMP-1 (Figure 2.8A). All four
proteins were enriched in fractions 4-6 compared to the post nuclear lysate. These

E) Live cell confocal images of Lysotracker Red-loaded YTS-MyoIIA-GFP (D) or YTS-GFP (E)
cells conjugated with KT86 target cells. The DIC image taken at 0 min is shown (left). Top
panels show an overlay of Myosin IIA-GFP (YTS-MyoIIA-GFP) or GFP (YTS-GFP) (green)
with Lysotracker Red (red); bottom panels use a pseudocolor scale to show intensity of GFP
only (Lysotracker Red fluorescence was removed prior to applying color scale). In all images,
an intensity threshold has been applied to the fluorescent signal so that only 3 SD above the
mean intensity for each fluorophore is shown. Scale bars = 10 µm. (F-G) Mean percent ±SD
Lysotracker Red fluorescent area colocalized with myosin IIA-GFP fluorescent area (F) and
mean percent ±SD myosin IIA-GFP colocalized with Lysotracker Red (G) in YTS-Myosin IIAGFP cells over time after conjugation with KT86 target cells (black lines). Red lines indicate
percent colocalized fluorescent areas ±SD in unconjugated cells over time. (H) Mean GFP
fluorescence intensity ±SD over time at the colocalized area between myosin IIA-GFP and
Lysotracker Red after conjugation to target cells. (I) Mean percent ±SD Lysotracker Red
fluorescent area colocalized with GFP fluorescent area of YTS-GFP cells over time after
conjugation with KT86 target cells (black line). Red line indicates percent colocalized area
±SD in unconjugated cells. All graphs represent live cell image sequences of ≥8 conjugates.
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Figure 2.7. Evaluation of fluorescence in fixed cell conjugates.
(A) The percent colocalization among fluorescent volumes in ≥ 8 YTS-GFP (gray) and YTSMyosin IIA-GFP (black) NK cells conjugated to KT86 target cells was calculated to
demonstrate the percentage of myosin IIA volume colocalized with GFP (M/G), GFP
colocalized with myosin IIA (G/M), perforin colocalized with GFP (P/G), and GFP colocalized
with perforin (G/P), ±SD. (B) The percent colocalization among fluorescent volumes in ≥ 8
YTS (white), YTS-GFP (gray), and YTS-Myosin IIA-GFP (black) NK cells conjugated to KT86
target cells was calculated to demonstrate the percentage of myosin IIA volume colocalized
with perforin (M/P) and perforin colocalized with myosin IIA (P/M), ±SD.

fractions contained 80-90% of the total protein in the granule fractions. There was a
paucity of actin in lytic granule fractions, demonstrating the general lack of cellular
contamination (Figure 2.8A). Myosin IIA-containing lytic granule fractions possessed
granzyme A activity (Figure 2.8B) and were able to kill 51Cr-labeled KT86 and 721.221
target cells (Figure 2.8C,D). The presence of myosin IIA in these fractions was verified
by mass spectrometry, as were perforin and granzyme B (Figure 2.8E and data not
shown). This association was also observed by confocal microscopy. Lytic granules
isolated from YTS-MyoIIA-GFP cells and loaded with Lysotracker Red demonstrated red
and green fluorescence in granule-sized organelles (Figure 2.8F). The association
between myosin IIA and lytic granules did not change after target cell conjugation, as
granules prepared from unconjugated and conjugated YTS cells had a similar amount of
myosin IIA when compared to the amount of granzyme B by Western blot analysis
(Figure 2.9).
To ensure that our results were not specific to YTS cells and to determine if 1933x
myosin IIA affected interaction with lytic granules, granules were isolated from control
donor and patient culture-propagated NK cells. In both normal donor and patient lytic
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granules, myosin IIA co-migrated with granzyme B (Figure 2.8G,I) and with granzyme A
activity (Figure 2.8H,J), implying that myosin IIA associates with human NK cell lytic
granules. To determine if the mutant myosin IIA was capable of interacting with lytic
granules, we utilized the two different myosin IIA antibodies used in Figure 2.2. If only
wild-type myosin IIA were associated with lytic granules, the densitometric ratio of bands
detected with the two different antibodies should approach 1.0. As expected, this ratio
approximated 1 in control donor lytic granules (Figure 2.8G), but did not in patient lytic
granules (Figure 2.8I). Thus, both wild type and mutant myosin IIA was associated with
lytic granules from patient NK cells. The densitometric ratio of total myosin IIA to
granzyme B was similar in patient and control lytic granules, however, and therefore the
total quantity of myosin IIA was not reduced in patient granules compared to control
(Figure 2.8G,I).
To gain greater insight into how lytic granule-associated myosin IIA could contribute
to function, we next attempted to determine the precise localization of myosin IIA on NK
cell lytic granules. We first performed immuno-electron microscopy on intact
unconjugated control donor eNK cells as well as isolated YTS cell lytic granules. In
unconjugated eNK cells, myosin IIA was identified on the periphery of lytic granules
(Figure 2.10A). This was confirmed by EM analysis of isolated lytic granules, which
were decorated with anti-myosin IIA antibody (Figure 2.10B), but not secondary antibody
alone (Figure 2.10C). As an additional approach, isolated lytic granules were surface
biotinylated, followed by precipitation of granule surface proteins with streptavidinagarose. Here, myosin IIA was identified in the precipitate from biotinylated lytic
granules, but not unlabeled lytic granules (Figure 2.10D). Overall, these data suggest
that myosin IIA is associated with lytic granules in NK cells and is located on their
surface and not in the core of these organelles. In this location, it may be poised to
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Figure 2.8. Evaluation of myosin IIA in isolated NK cell lytic granules.
Fractions from density gradient separation of lytic granules from YTS (A-E), YTS-Myosin IIAGFP (F), control NK (G-H), and 1933X NK (I-J) cells. (A, G, I) Myosin IIA, granzyme B,
LAMP-1, perforin, and actin Western blot of density gradient fractions, from least (1) to most
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facilitate the interaction of lytic granules with actin and their penetration into the F-actinrich IS.
Myosin IIA-associated lytic granules can bind F-actin
To demonstrate a potential function of lytic granule-associated myosin IIA, we
examined the ability of isolated NK cell lytic granules to bind F-actin using a
centrifugation-based assay. Lytic granules were incubated in the presence of F-actin
and then subjected to centrifugation at a speed which pellets lytic granules, but not Factin alone. Addition of YTS cell lytic granules to F-actin resulted in the presence of Factin in the lytic granule pellet and reduced F-actin in the residual supernatant (Figure
2.11A,B). The percent of F-actin pelleted by the lytic granules was similar to that
obtained in the pellet after addition of the actin bundling protein α-actinin, which was
used as a positive control to aggregate F-actin. Transmission EM of the pellet from lytic
granules added to F-actin demonstrated filamentous material associated with the lytic
granules (Figure 2.11E); the granule pellet alone without added F-actin did not (Figure
2.11F). Similarly, Western blot of the granule pellet from the control portion of this
assay, in which F-actin was not added, did not demonstrate the presence of actin
(Figure 2.11A). Thus, the presence of actin in the pellet after addition of exogenous Factin defines a specific interaction between lytic granules and F-actin.
dense (7) as well as the post-nuclear lysate (PNL) and crude lysosomal fraction (CLF) generated
in preparing the starting material for the density gradient. In (G, I), anti-myosin IIA antibodies with
specificities for both wild type and 1933x myosin IIA (top), or only wild-type myosin IIA (middle).
Densitometric ratios of total to wild-type epitope recognizing antibody signal, as well as total
myosin IIA to granzyme B, are shown below the Western blots. (B, H, J) Serine esterase activity
of YTS (B), control NK (H), and 1933x NK cell (J) density gradient fractions. (C-D) Cytotoxicity of
KT86 (C) and 721.221 (D) target cells mediated by YTS density gradient fractions. (E) Mass
spectrometric analysis of peptides identified in a density gradient fraction from YTS cells enriched
in myosin IIA and granzyme B, identifying MYH9 in the bands demonstrated in the Western blots.
The diagram (left) depicts peptide coverage of MYH9, and the mass spectra (right) represent the
most N-terminal and most C-terminal peptides identified. (F) Confocal fluorescent images of
isolated lytic granules from YTS-Myosin IIA-GFP cells (gradient fractions 5 and 6) loaded with
Lysotracker Red. Presumed lytic granules (arrows) demonstrated both Lysotracker (red) and
myosin IIA-GFP (green) fluorescence. Scale bar = 4 µm. Mass spectrometry was performed with
the assistance of the Stokes Protein Core Facility at Children’s Hospital of Philadelphia.
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Figure 2.9. Biochemical analysis of myosin IIA accumulation in the lytic granule
fraction (fraction 6) before and after physiologic YTS activation.
Quantitative analysis of mean myosin IIA to granzyme B ratio ±SD from Western blots using
three independent lytic granule preparations from YTS cells. YTS cells and KT86 cells were
either conjugated (black) or left unconjugated and lysed separately prior to lytic granule
isolation (gray).

To confirm that this property of NK cell lytic granules was not specific to YTS cells,
and to evaluate the effect of 1933x myosin IIA, F-actin-binding assays with isolated lytic
granules from control donor and patient NK cells were performed. The addition of
control, but not patient, NK cell lytic granules to F-actin resulted in actin in the lytic
granule pellet and reduced actin in the residual supernatant (Figure 2.11C,D). Overall,
while control donor NK cell lytic granules were able to associate with nearly the same
amount of F-actin as the positive control (86±2% of the quantity removed from the
supernatant by α-actinin determined by densitometry of actin bands), granules from
1933x patient NK cells could only associate with less than half of the amount of F-actin
as positive control (42±3% of α-actinin). This demonstrates that normal human NK cell
lytic granules can bind F-actin and suggests that 1933x myosin IIA reduced the ability of
patient lytic granules to interact with F-actin. This implies a specific role for lytic granuleassociated myosin IIA in F-actin binding.
To directly observe the binding of the isolated lytic granules to F-actin, we
constructed microflow chambers coated with biotinylated BSA and streptavidin (BSA/SA,
Figure 2.12), or BSA/SA and F-actin stabilized with biotinylated phalloidin (Figure 2.12),
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Figure 2.10. Ultrastructural localization of myosin IIA in NK cells and isolated
lytic granules.
(A) Electron micrograph of an unconjugated eNK cell stained with rabbit anti-myosin IIA Ab
followed by gold-conjugated anti-rabbit Ab. LG = lytic granule. Arrows indicate areas
containing gold particles. Scale bar = 500 nm. (B) Electron micrograph of isolated lytic
granules from YTS cells stained with rabbit anti-myosin IIA Ab followed by gold-conjugated
anti-rabbit Ab. Arrows indicate areas containing gold particles. Scale bar = 500 nm. (C)
Electron micrograph of isolated lytic granules from YTS cells stained with gold-conjugated
anti-rabbit Ab alone. Scale bar = 500 nm. Arrows indicate gold particles. (D) Western blot of
streptavidin-agarose immunoprecipitates from unlabeled lytic granules (No Bio) and surfacebiotinylated lytic granules (Bio), and whole cell lysate (WCL) from YTS cells. Electron
microscopy was performed with the assistance of Raymond Meade and Neelima Shah.

to which lytic granules were added. We initially studied lytic granules from YTS-MyoIIAGFP cells, which were visible by confocal fluorescence microscopy due to the presence
of myosin IIA-GFP. When suspended in a physiologic salt buffer and added to a
BSA/SA-coated microflow chamber, the lytic granules did not adhere to the coated glass
surface (Figure 2.13A,B and Video 4A). When added to an F-actin-coated microflow
chamber, however, the granules adhered to the chamber, despite continued flow of
buffer (Figure 2.13A,B and Video 4B). After lytic granules were stable in their position,
buffer was changed from physiologic salt to high salt containing 5 mM ATP, which
abrogates myosin II binding to F-actin by first causing myosin II detachment from actin
through its ATP-dependent motor activity and then preventing rebinding through the
presence of high salt (Yanagida et al., 1985). Under these conditions, most granules no
longer adhered to the microflow chamber (Figure 2.13A,B and Video 4C). The granules
did not begin to move through the chamber upon addition of high-salt buffer containing
no ATP (data not shown), suggesting that the granules are released from F-actin by the
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Figure 2.11. Interaction between myosin IIA-associated lytic granules and F-actin.
Lytic granules from an isolated fraction enriched in myosin IIA and granzyme B were prepared
from YTS (A-B, E-F), control NK (C), and myosin IIA 1933x patient NK (D) and incubated for
30 min in the presence or absence of F-actin. After centrifugation at 18,000g, the pellet (P)
and supernatant (S) were evaluated for actin and granzyme B by Western blot (A, C, D). As
a positive control, α-actinin was used to bundle the F-actin, causing it to pellet. Pellet and
supernatant from the assay were separated. (B) Percentage of actin in the pellet ±SD from
three independent experiments, determined by densitometric analysis. *= p<0.05 compared
to buffer (negative control). (E-F) Electron micrographs of lytic granule pellets. The pellet
obtained from the mixture of lytic granules and F-actin (E) was compared to the pellet of lytic
granules alone (F). Scale bar = 500 nm. Electron microscopy was performed with the
assistance of Raymond Meade.

addition of ATP. Granules that were pretreated with blebbistatin also failed to properly
adhere to F-actin-coated chambers (Figure 2.13A), further implicating a specific role for
myosin II.
To confirm that these properties of YTS-MyoIIA-GFP-derived lytic granules were
relevant to primary human NK cells and to define the effect of 1933x myosin IIA, lytic
granules prepared from culture-propagated control and patient eNK cells were loaded
with Lysotracker Green and evaluated in the microflow chambers. In F-actin-coated
chambers with physiologic salt buffer, control, but not patient, granules adhered to the
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Figure 2.12. Actin-coated microflow chambers.
TIRF images of microflow chambers coated with BSA and streptavidin (BSA/SA, left) and
BSA/SA/Actin (right) for actin-binding assay in Figure 2.13. Actin filaments are visualized
using AlexaFluor 488-Phalloidin (light blue). TIRF was performed with the assistance of
Gregory Rak.

coated glass surface similarly to the YTS-MyoIIA-GFP granules (Figure 2.13C,D and
Videos 5A,6A). Upon exposure to high-salt buffer containing ATP, granules from both
control donor and patient eNK cells were not adherent to the F-actin-coated chamber
(Figure 2.13C,D and Videos 5B,6B). These results demonstrate a direct interaction
between NK cell lytic granules and F-actin and suggest a critical role for intact myosin
IIA function in this process.
Myosin II function is necessary for lytic granule approach to the IS
Since we found that NK cell lytic granules adhere to F-actin, we wanted to determine
if myosin IIA could facilitate granule movement through the F-actin dense cell cortex. To
test this, we used TIRF microscopy to image granules at the activated surface of YTS
cells. We have previously shown that YTS cells polarize their lytic granules to and
accumulate F-actin at anti-CD28-coated glass surfaces within 30 minutes (Banerjee et
al., 2007). Thus, Lysotracker Green-loaded YTS cells were adhered to anti-CD28coated environmental chambers for 25 minutes, and lytic granule polarization toward the
contact site was determined using confocal fluorescent z-axis sectioning (Figure 2.14A).
Cells with polarized lytic granules were then imaged in TIRF mode at a maximum
acquisition rate for 30 seconds. In control YTS cells, lytic granules were dynamically
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Figure 2.13. Functional association of lytic granules with F-actin and effects of
ATP and myosin IIA 1933x.
Isolated lytic granules were added to flow chambers containing biotinylated BSA/streptavidin
(BSA/SA) without actin, with actin and physiologic salt buffer, or with actin and ATP-containing
high-salt buffer, or with actin using blebbistatin-treated granules. Granules from YTS-MyoIIAGFP (A), control NK (C), and 1933x NK (D) cells were drawn through the chamber and
allowed to flow through or adhere for 1-2 min before imaging with a confocal microscope at
approx. 5 time points per second. From any single culture propagated NK cell preparation the
quantity of lytic granules obtained was sufficient for flow through only two chambers. Images
were analyzed using the object tracking function in Volocity software and represent an overlay
of 12 to 45 seconds. Individual moving objects which had displacement greater than 5 µm
(red) and displacement less than 5 µm (white) are indicated. Scale bar = 40 µm. Some
images are rotated from their original orientation, shown in Videos 4A-6B. (B,E) Number of
moving objects per second ±SD in 3-5 independent sequences of isolated YTS-Myosin IIAGFP (B) and control and 1933x NK cell (E) lytic granules added to flow chambers. *= p<0.05.

evident in the zone of TIRF illumination (Figure 2.14A and Video 7A). To evaluate a role
for myosin II in this activity, YTS cells were pretreated with the myosin light chain kinase
inhibitor ML-9, which inhibits myosin II function (Saitoh et al., 1987). ML-9 was used in
this capacity for TIRF applications due to the phototoxicity of blebbistatin at 488 nm
(Kolega, 2004). ML-9-treated cells still polarized lytic granules toward the antibodycoated glass (Figure 2.14A), but there were fewer lytic granules in the zone of TIRF
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Figure 2.14. Evaluation of myosin IIA in lytic granule dynamics.
(A) Control or ML-9-treated YTS cells with polarized lytic granules (as determined by confocal
fluorescent microscopy, at left) were imaged on an anti-CD28-coated glass surface using
TIRFm for 30 seconds at a rate of 5 images per second. Scale bar = 5 µm. Representative
cells of 11 individually analyzed cells for each condition are shown and were chosen based
upon their representation of the median number of tracks of all cells analyzed. (B) Change in
2
area over time for individual granules in the representative cells. y-axis was divided at 1 µm
as exceeding values were likely not to represent individual granules but rather conglomerates.
(C) Mean ±SD lytic granule area for the cells depticted in (A,B) is shown over the number of
timepoints representing the mean duration of tracks in ML-9-treated cells. The mean number
of timepoints in the control-treated YTS cell tracks (red) was less than in the ML-9-treated
cells (blue). (D-I) The total number of tracks (D), mean track length (E), mean track velocity
(F), mean number of timepoints for tracks (G), mean track displacement (H), mean track
displacement rate (I) plotted to show each of 11 independent control and ML-9-treated
replicate cells, ±SD. Red points in each condition indicate the representative cell shown in (A)
and (B). Difference between the means of control and ML-9-treated cells in (D,E,F,H) was
significant (p<0.05), and in (I) demonstrates a trend (p<0.1). TIRF microscopy was performed
with the assistance of Gregory Rak.
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illumination. Furthermore, the lytic granules which were apparent were less dynamic
(Figure 2.14A and Video 7B).
To quantify the effect of ML-9 treatment on lytic granule dynamics, individual lytic
granules from multiple control and ML-9-treated cells were identified, measured, and
tracked throughout the duration of imaging. In control cells, granule area fluctuated over
time, suggesting that granules were constantly moving toward and away from the NK
cell membrane. In ML-9-treated cells, however, granule area was generally small and
remained constant throughout imaging (Figure 2.14B,C). Relative to control, ML-9treated cells had a lower mean number of lytic granule tracks (Figure 2.14D), which had
less velocity, track length, total displacement and rate of displacement (Figures
2.14D,F,H,I). The mean duration of each track was not different between control and
ML-9-treated cells (Figure 2.14G). Thus, lytic granule approach to and movement at the
IS is diminished by ML-9 treatment. This suggests a critical role for myosin II in this
prefinal step in NK cell cytotoxicity, where lytic granules traverse the cell cortex to reach
the NK cell plasma membrane.

Discussion
NK cell cytotoxicity occurs largely through the directed exocytosis of lytic granule
contents onto target cells. Previously, myosin IIA was shown to be dispensable for NK
cell conjugation with target cells, IS formation, and lytic granule polarization towards the
IS, but required for degranulation (Andzelm et al., 2007). Here, using NK cells from four
patients with a mutation in myosin IIA, we identify a mechanism for myosin IIA function in
NK cells. Specifically, myosin IIA associates with lytic granules and enables their
interaction with F-actin as well as their final approach to the IS.
This function of myosin IIA is likely critical, as there is a substantial accumulation of
F-actin at the IS, which could prevent a large organelle such as a lytic granule (up to 1
µm in diameter (Burkhardt et al., 1990)) from reaching the cell membrane. Clearances in
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cortical actin have been identified at the secretory domain in CTLs (Stinchcombe et al.,
2001b) and subsequently in NK cells (Vyas et al., 2001). It was unclear, however,
whether lytic granules require assistance in navigating a course through the actin cortex
surrounding the secretory domain once they have reached the IS. In our studies of
myosin IIA 1933x patient or blebbistatin-treated NK cells, we have found diminished
colocalization between perforin and F-actin at the IS (Figure 2.2), suggesting that
functional myosin IIA is necessary for lytic granule penetration into the F-actin cortex at
the IS. Myosin IIA is unlikely to function at the lytic IS in large-scale restructuring of Factin, as overall F-actin organization at the IS was previously reported as normal in
blebbistatin-treated cells (Andzelm et al., 2007), although minor contributions of myosin
IIA at the IS in readjusting the actin cortex cannot be excluded.
In the present work, we found that myosin IIA was directly and constitutively
associated with lytic granules using several techniques (Figures 2.2,2.6,2.8). Although
we identified myosin IIA in lytic granule preparations in both YTS and donor-derived NK
cells (Figure 2.8), it is possible that myosin IIA was present in these preparations due to
an association with organelles of similar density to lytic granules. This is unlikely,
however, as myosin IIA was visualized with isolated lytic granules by confocal
microscopy (Figure 2.8) and was at the periphery of lytic granules in ultrastructural
analyses of intact eNK cells and isolated lytic granules (Figure 2.10). Localization at the
periphery of these organelles is important because this would allow myosin IIA to serve
a functional role on intact granules. The constitutive association of myosin IIA with lytic
granules (Figures 2.6,2.8,2.9) suggests that myosin IIA is unlikely to be recruited to lytic
granules upon NK cell activation, although rapid turnover of granule-associated myosin
IIA cannot be excluded. The association of myosin IIA with lytic granules would be akin
to the functions of certain myosin isoforms in other cell types. Examples include myosin
V (reviewed in (Langford, 2002)) and myosin II (DePina and Langford, 1999; DePina et
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al., 2007; Heimann et al., 1999; Ikonen et al., 1997; Neco et al., 2008; Neco et al., 2004),
which are implicated in vesicle transport. Myosin IIA, specifically, has also been linked
to degranulation in mast cells (Holst et al., 2002; Ludowyke et al., 2006), although it is
unclear whether myosin IIA is associated with mast cell granules or is involved in
remodeling the cytoskeleton in these cells. Our findings expand upon the role of myosin
IIA in organelle transport, indicating a specialized and direct role for myosin IIA in the
transport of NK cell lytic granules.
The association of myosin IIA molecules to lytic granules could potentially occur
directly through the granule membrane. The C-terminal fragment of myosin IIA can bind
to phosphatidylserine-containing vesicles (Li et al., 1994; Murakami et al., 1994), and
this property could enable a similar association with lytic granules. Alternatively, myosin
IIA may associate with lytic granules in an indirect fashion, as demonstrated by the
cooperative binding of myosin V with rab27a and melanophilin to melanosome
membranes (Wu et al., 2006). Since myosin IIA has been previously identified in NK
cells to exist in a complex with WIP and WASp (Krzewski et al., 2006), and WIP has
been identified in NK cell lytic granule preparations (Krzewski et al., 2008), myosin IIA
could potentially associate with lytic granules through this complex.
The specific association of myosin IIA with lytic granules may point to an inherent
ability of lytic granules to reach the cell membrane once delivered to the cortex. Myosin
IIA-associated lytic granules isolated from NK cells are capable of adhering to F-actin,
even under the force of flow (Figure 2.13). The sensitivity of this interaction to ATP and
high salt implies that the protein or proteins responsible are regulated by ATP, a known
property of myosins. There is a possibility that other actin-binding proteins associated
with the granules may stabilize this interaction, but additional ATP-dependent actinbinding motor proteins were not identified in our proteomic analysis of lytic granule
contents (data not shown), or in those published by others (Casey et al., 2007). A role
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for myosin IIA in the final approach of lytic granules to the IS was further identified in ML9-treated NK cells using TIRF microscopy (Figure 2.14), despite the fact that granule
polarization occurred (Figure 2.14A), as previously demonstrated (Andzelm et al., 2007).
This implies a role for myosin IIA in transporting lytic granules to the plasma membrane
following their delivery to secretory domains at the IS. This function is likely to be
specific for lytic granules, as IFN-γ secretion was not affected in blebbistatin-treated cells
(Figure 2.4), a distinction further supported by studies defining differential regulation of
degranulation and IFN-γ production in NK cells (Colucci et al., 2001; Vahlne et al., 2008).
The role for myosin IIA in NK cell lytic granule function was additionally
demonstrated by NK cells from rare patients with May-Hegglin Anomaly due to a 1933x
mutation in myosin IIA. Patient NK cells had defective cytotoxic activity and lytic
granules which poorly colocalized with F-actin (Figure 2.1), again suggesting that
functional myosin IIA may be necessary for lytic granule entry into F-actin at the cell
cortex. While one of the four patients we evaluated had an atypical infection (with
Listeria) which has been shown to involve NK cell-mediated defense (Berg et al., 2005),
it is presently unclear if this defect is of clinical significance due to the small number of
patients available for study with this mutation. A more comprehensive clinical
assessment of patients with this particular, as well as other, MYH9 mutations is
warranted.
The 1933x mutation affects the domain of myosin IIA involved in filament formation
and cargo binding (Murakami et al., 1994). It does not prevent formation of heavy chain
dimers, but does result in abnormal bipolar myosin IIA filaments (Franke et al., 2005).
These potential effects of myosin IIA 1933x in filament formation and/or cargo binding
suggest two different mechanisms of how myosin IIA associates with lytic granules.
First, myosin IIA could form bipolar filaments which wrap around lytic granules. In this
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case, the presence of the 1933x mutant in myosin IIA heterohexamers would alter
filament structure and reduce F-actin binding capabilities, potentially due to poor filament
contractility. Our data demonstrate that the quantity of myosin IIA associated with lytic
granules is normal in patient NK cells (Figure 2.8), but the function in interacting with Factin is decreased (Figures 2.11,2.13). As a second potential mechanism, several
myosin IIA molecules could associate with NK cell lytic granules in single hexameric
units. Although one independent myosin IIA unit would have minimal processivity,
multiple molecules could cooperate to enable granule interaction with F-actin (De La
Cruz and Ostap, 2004). Single myosin IIA units attached to granules might lead to the
directional rolling of granules along F-actin, while myosin IIA filament-wrapped granules
might predict more random dynamics of individual granules. Further studies defining
these interactions hold the potential to identify novel mechanisms of myosin IIA function.
Regulation of myosin IIA could also represent an important means for controlling lytic
granule interaction with F-actin, and may be affected by the 1933x mutant myosin. A
casein kinase II phosphorylation site exists at S1943 of the myosin IIA heavy chain
(Murakami et al., 1998), and is removed by the 1933x mutation. Additionally, PKCmediated phosphorylation of S1916 (Conti et al., 1991; Moussavi et al., 1993) could be
altered in the 1933x protein, as interaction of PKC with myosin IIA may be stabilized by
the C-terminus of the protein. Regulation of myosin IIA through C-terminal
phosphorylation has been established in murine T cells (Jacobelli et al., 2004),
suggesting that mutations disrupting phosphorylation sites may alter immunologic
functions. The 1933x mutation may also affect interactions with mts1/S100A4, which is
known to bind between residues 1909-1937 of myosin IIA and regulate myosin IIA
phosphorylation states (Kriajevska et al., 1998). Alterations in myosin IIA
phosphorylation state could result in decreased function in binding to or movement
across F-actin.
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In cytotoxic lymphocytes, lytic granules are brought to the secretory domain by the
MTOC, which approximates the cell membrane in cytolytic conjugates (Stinchcombe et
al., 2006). Myosin IIA may facilitate the final transport of NK cell lytic granules through
the F-actin cortex at the IS. Given that NK cells maintain abundant lytic granules at rest,
this mechanism of tight control may be warranted. Additional identification of how
myosin IIA is regulated to promote lytic granule exocytosis may therefore uncover
important controls for NK cell cytotoxicity. The constitutive and functional association of
myosin IIA with lytic granules, however, defines a critical requirement for accessing NK
cell activity.
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Chapter 3: Phosphorylation of the myosin IIA tailpiece regulates
association of single myosin IIA molecules with NK cell lytic
granules to promote NK cell cytotoxicity 3

Summary
Natural killer (NK) cells are innate immune lymphocytes that provide critical defense
against virally infected and transformed cells. NK cell cytotoxicity requires the formation
of an F-actin rich immunological synapse (IS), as well as the polarization of perforincontaining lytic granules to and secretion of their contents at the IS. We have previously
reported that NK cell cytotoxicity requires nonmuscle myosin IIA function, and that
granule-associated myosin IIA mediates the interaction of granules with F-actin at the
IS. Here, we evaluate the nature of the association of myosin IIA with lytic granules.
Taking the lead from NK cells from patients with mutations in myosin IIA, we find that the
nonhelical tailpiece is required for NK cell cytotoxicity and the phosphorylation of
granule-associated myosin IIA. Using ultra-resolution imaging techniques, we
demonstrate that single myosin IIA molecules associate with NK cell lytic granules via
the nonhelical tailpiece. We also find that phosphorylation of myosin IIA at residue
S1943 in the tailpiece is needed for this linkage. This defines a novel mechanism for
myosin II function, where myosin IIA can act as a single-molecule actin motor, claiming
granules as cargo through tail-dependent phosphorylation for the execution of a prefinal
step in human NK cell cytotoxicity.

3

A version of this chapter has been submitted for publication as:

Sanborn KB, Mace EM, Rak GD, Difeo A, Martignetti JA, Pecci A, Bussel JB, Favier R, Orange JS.
Phosphorylation of the myosin IIA tailpiece regulates association of single myosin IIA molecules
with NK cell lytic granules to promote NK cell cytotoxicity.
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Introduction
Natural killer (NK) cells are lymphocytes of the innate immune system that provide
critical defense against viral infections and cancer. NK cells respond to infected or
transformed cells by directly killing the target cells, and also secrete cytokines and
provide co-stimulation to promote immune responses (reviewed in (Vivier et al., 2008)).
NK cell activation takes place in a series of steps, beginning with adhesion signaling and
the dynein-mediated convergence of lytic granules to the microtubule organizing center
(MTOC, (Davis et al., 1999)). Following early adhesion signaling, the NK cell forms an
array of adhesion and activation receptors termed the immunological synapse (IS,
reviewed in (Orange, 2008)). The IS is stabilized by these receptor interactions, as well
as the polymerization of a dense layer of filamentous actin (F-actin) at the contact site
(Carpen et al., 1983). Once an NK cell forms a mature IS, NK cell activation directs the
polarization of lytic granules along with the MTOC to the IS (Mentlik et al., 2010). When
the NK cell secretory machinery has polarized in the direction of a target cell, lytic
granule contents, including the pore-forming molecule perforin and apoptosis-inducing
granzymes, are secreted at the plasma membrane and direct target cell lysis (reviewed
in (Hoves et al., 2009)).
Although NK cell lytic granules are delivered to the IS via association with
microtubules and can dock at the plasma membrane for secretion, the dense layer of Factin at the IS may present a barrier to secretion of granule contents at the plasma
membrane (reviewed in (Sanborn and Orange, 2010)). Thus, transport across actin
filaments may be required for lytic granules to reach the plasma membrane. As ATPdependent motor molecules that generate movement across actin filaments, members of
the myosin superfamily are ideal for this role. Myosin superfamily members have critical
roles in immune cells, and are required for cell motility, migration, and adhesion (Deng et
al., 1999). In NK cells, nonmuscle myosin IIA has been defined as a critical regulator of
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NK cell cytotoxicity (Sanborn et al., 2009). Myosin IIA is a hexameric protein composed
of two heavy chains, two regulatory light chains, and two essential light chains (reviewed
in (Eddinger and Meer, 2007)). The N-terminal head portion of the heavy chain is
important for its ATPase function and actin binding, while the C-terminal rod domain and
nonhelical tailpiece are critical for regulating filament formation and cargo binding
(reviewed in (Ricketson et al., 2010)). Myosin IIA function is required for NK cell
cytotoxicity, as NK cells treated with the myosin II inhibitor blebbistatin or with siRNA
against myosin IIA have reduced cytotoxicity against target cells (Andzelm et al., 2007).
Although myosin IIA is not required for conjugation with target cells, IS formation, or lytic
granule polarization to the IS (Andzelm et al., 2007), it does associate with NK cell lytic
granules (Sanborn et al., 2009). The motor function and tailpiece of myosin IIA are
required for the interaction of lytic granules with F-actin (Sanborn et al., 2009), and thus
the requirement for myosin IIA is specific to lytic granule exocytosis due to its role in
enabling granule localization into F-actin at the IS. The mechanism for the requirement
for the tailpiece and the nature of the association of myosin IIA with lytic granules,
however, remain unclear.
Mutations in the myosin IIA heavy chain, MYH9, cause several disorders including
May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein
syndrome, which are now collectively known as MYH9-related disease (MYH9-RD).
MYH9-RD is characterized by macrothrombocytopenia and leukocyte inclusions, with
mutations in some regions of the protein causing the occurrence of additional symptoms
such as cataracts, deafness, and glomerulonephritis (Seri et al., 2003). While immune
function is not typically evaluated in patients with MYH9-RD, we previously identified a
deficiency in NK cell cytotoxicity in patients with a C-terminal truncation of MYH9 at
position 1933 (Sanborn et al., 2009). In the present study, we evaluate the role of each
major functional region of myosin IIA in NK cell cytotoxicity using NK cells from patients
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with MYH9-RD, and define a specific requirement for the myosin IIA head domain and
nonhelical tailpiece. We further demonstrate that myosin IIA interacts with lytic granules
as a single molecule rather than as a filament, an interaction that is regulated by
phosphorylation of the myosin IIA tailpiece at residue Ser1943.

Results
Human NK cells with mutations in the myosin IIA head or tailpiece have impaired
cytotoxicity.
We have previously demonstrated that a truncation mutation in the tailpiece of
myosin IIA reduces NK cell cytotoxic function (Sanborn et al., 2009). To further examine
the role of each region of myosin IIA in NK cell function, we evaluated patients with
MYH9-RD due to mutations in each portion of MYH9. Common clinical findings in
MYH9-RD include macrothrombocytopenia, leukocyte inclusions, cataracts, deafness,
and nephritis (Seri et al., 2003). The patients in this study demonstrated some or all of
these depending on their specific MYH9 mutation (Table 3.1), in accordance with
previous reports of variable effects of MYH9 mutations (Pecci et al., 2008). To
determine the effect of these mutations upon NK cell cytotoxicity, ex vivo NK (eNK) cells
from these patients were prepared from peripheral blood and evaluated for their ability to

Table 3.1. Mutations and phenotype of patients with MYH9-RD.
Position of mutation of each patient with MYH9-RD is listed, along with the presence of
symptoms including macrothrombocytopenia, Döhle bodies, presenile hearing loss,
glomerulonephritis, and cataracts. n.d., not determined. Clinical evaluation of patients was
performed by Drs. James Bussel and Alessandro Pecci.
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Figure 3.1. Effect of naturally occurring mutations in MYH9 on human NK cell
cytotoxicity.
(A) Schematic depicting the major functional regions of a myosin IIA molecule, indicating the
position of MYH9 mutations in patients whose NK cells were used in this study. (B) Cytotoxic
activity of negatively selected, purified ex vivo human NK cells from patients with mutations in
the head (S96L), S2 (T1155I), rod (R1400W, D1424N), and tail (5779delC) domains of MYH9
51
was compared to control donors in Cr-release assays against K562 target cells. Results from
1933x patients are previously published, and are shown for comparison. Results are listed as
lytic units required for 10% lysis of target cells (LU10), and patient cell LU10 is normalized to
control for each assay. Where more than one patient with a specific mutation was analyzed,
the mean +SD is shown.

kill K562 erythroleukemia cells.
The N-terminal head region of MYH9 is critical for binding to F-actin and ATP
hydrolysis for motor function, which requires the flexibility of the neighboring
subfragment 2 (S2) portion for myosin head motility (Eddinger and Meer, 2007). NK
cells derived from patients with the S96L mutation in the head region and T1155I
mutation in the S2 region (Figure 3.1A) demonstrated a reduced ability to lyse K562
target cells compared to control eNK cells (Figure 3.1B), suggesting a role for myosin IIA
motor function in NK cell cytotoxicity, in accordance with previous studies (Sanborn et
al., 2009). In contrast, although the helical rod portion of myosin IIA is critical for
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Figure 3.2. Expression of GFP-tagged myosin IIA and mutants.
Western blot of whole cell lysate from YTS cells and YTS cells expressing GFP alone (YTSGFP), wild-type myosin IIA-GFP (MIIA-GFP), 1933x myosin IIA-GFP (1933x-GFP), or S1943A
myosin IIA-GFP (S1943A-GFP). Evaluation of GFP and myosin IIA signal was performed on a
fluorescence scanner, and overlay of GFP (red) and myosin IIA (blue) signal is shown in the
top panel (250 kDa), as well as GFP alone in the bottom panel (25 kDa).

formation of bipolar myosin II filaments (Franke et al., 2005), two mutations in the rod
region, R1400W and D1424N (Figure 3.1A), affected cytotoxicity to a lesser extent
(Figure 3.1B). The variability in cytotoxicity of NK cells from patients with the D1424N
mutation may be due to variable penetrance of the mutation and instability of the mutant
protein, as suggested in other studies (Deutsch et al., 2003).
The nonhelical tailpiece at the C-terminus of myosin IIA is required for binding to
cargo, as well as for regulation of the protein (Sandquist and Means, 2008). This area
can also bind to regulatory elements at residues 1916 and 1943, as well as to
phospholipid membranes (Fath, 2005). We previously demonstrated that a truncation of
the nonhelical tailpiece at residue 1933 diminishes NK cell cytotoxicity (Sanborn et al.,
2009). Similar to patients with the 1933x truncation mutation, eNK cells from a patient
with the 5779delC mutation (Figure 3.1A), which causes a frameshift at residue 1927
that results in a truncation of the protein at residue 1942 (Kunishima et al., 2001b), have
reduced cytotoxic function compared to control cells (Figure 3.1B). Although studies of
additional patients with MYH9 mutations are needed, these results suggest a specific
requirement for myosin IIA motor function and its nonhelical tailpiece in NK cell
cytotoxicity.
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The myosin IIA tailpiece is phosphorylated at Ser1943.
Because our results from patients with MYH9-RD suggested a specific requirement
for the MYH9 tailpiece in NK cell cytotoxicity, we wanted to determine the nature of this
requirement. Thus we generated an NK cell model system to study the role of the MYH9
tailpiece as instructed by the patient observations and created a YTS NK cell line
expressing the MYH9 1933x truncation (hereafter referred to as 1933x) as a GFP fusion
protein (YTS-1933x-GFP). These cells expressed the 1933x-GFP protein at levels of
approximately 20% that of endogenous myosin IIA (Figure 3.2). Similar to patients with
the 1933x mutation, the presence of the mutant myosin in YTS-1933x-GFP cells led to
reduced cytotoxicity compared to cells expressing a wild-type myosin GFP fusion protein
(YTS-MyoIIA-GFP). This was most readily apparent in 51Cr-release assays against
721.221 target cells with incubation times less than 4h (Figure 3.3). This may be due to
the presence of two copies of endogenous, non-mutated myosin IIA in the cell line,
unlike the patients, which are heterozygous for the 1933x mutation.
The tailpiece of myosin IIA is a site of regulation by phosphorylation in many cell
types (Conti et al., 1991; Jacobelli et al., 2004; Ludowyke et al., 2006; Murakami et al.,
1998). To evaluate the phosphorylation of the myosin tailpiece, we immunoprecipitated

Figure 3.3. The 1933x mutation in MYH9 reduces NK cell killing.
Cytotoxic activity of the YTS NK cell line stably expressing a 1933x myosin IIA-GFP fusion
51
protein was compared to YTS cells expressing wild-type myosin IIA-GFP in Cr-release
assays against 721.221 target cells. Results are listed as lytic units required for 20% lysis of
target cells (LU20), and 1933x-GFP LU20 is normalized to MIIA-GFP for each assay. Results
shown are the mean of three experiments, and error bars indicate SD.
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the GFP-tagged wild-type and 1933x myosins from resting NK cells and NK cells
conjugated to KT86 target cells, then compared their phosphorylation states. In all
cases, GFP immunoprecipitation resulted in the isolation of both GFP-tagged and
untagged myosin IIA (Figure 3.4A – upper band is the GFP fusion protein, and lower
band is endogenous), indicating that the two populations of myosin in the cells were able
to complex with each other. In GFP immunoprecipitates from cells expressing wild-type
myosin IIA, gel staining for phosphorylation revealed substantial phosphorylation of the
GFP-tagged myosin IIA as well as the endogenous protein (Figure 3.4A). The amount of
phosphorylation did not change upon conjugation with target cells. Compared to YTSMyoIIA-GFP cells, YTS-1933x-GFP cells demonstrated reduced phosphorylation of the
GFP-tagged protein, although equivalent quantities of protein were precipitated and the
endogenous protein remained phosphorylated (Figure 3.4A). Since we had previously
defined an association of myosin IIA with NK cell lytic granules (Sanborn et al., 2009),
we next wanted to specifically evaluate lytic granule-associated myosin IIA. Thus,
granules were isolated from YTS-MyoIIA-GFP and YTS-1933x-GFP cells and treated
with 2M NaCl to remove peripherally associated proteins for immunoprecipitation.
Similar to whole cells, immunoprecipitation of GFP-tagged myosins from lytic granuleassociated proteins demonstrated that granule-associated myosin IIA is constitutively
phosphorylated, and that the 1933x mutation decreases phosphorylation (Figure 3.4B).
This suggests that the MYH9 tailpiece is required for myosin IIA phosphorylation in NK
cells.
Because residue Ser1943 is a key site of myosin IIA phosphorylation (Moussavi et
al., 1993) and is removed by the 1933x truncation, we wanted to determine whether
Ser1943 is phosphorylated in NK cells. Using GFP immunoprecipitates from whole cell
lysate and isolated lytic granules, we evaluated Ser1943 phosphorylation in MyoIIA-GFP
and 1933x-GFP expressing YTS cells with an antibody specific for phospho-Ser1943.
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Figure 3.4. Myosin IIA is constitutively phosphorylated at Ser1943.
(A-D) YTS cells expressing wild-type myosin IIA-GFP (MIIA) or 1933x myosin IIA-GFP
(1933x) were left resting or were conjugated to KT86 target cells. GFP-tagged proteins were
immunoprecipitated from lysates (A,C) or from the supernatants of isolated lytic granules that
were treated with NaCl to remove surface proteins (B,D). GFP immunoprecipitates were
evaluated by gel stain for phosphorylation (Pro-Q) and total protein (Sypro) (A-B), or by
Western blot for phospho-Ser1943 and total myosin IIA (C-D). In (A-D), numbers below blots
indicate the ratio of the phosphorylated band intensity to the total protein intensity for the
GFP-tagged protein (upper band), normalized to the ratio for MIIA. (E) Resting and stimulated
ex vivo human NK cell lysates and lytic granules isolated from resting eNK evaluated by
Western blot for phospho-Ser1943 and total myosin IIA. In each image there are two myosin
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Wild-type myosin IIA was constitutively phosphorylated at Ser1943 in both whole cell
lysate and isolated lytic granules (Figures 3.4C-D). Due to the truncation upstream of
the residue in 1933x myosin, the 1933x-GFP protein did not demonstrate Ser1943
phosphorylation, however, the presence of the mutated myosin did not affect
phosphorylation of Ser1943 in endogenous myosin IIA (Figures 3.4C-D). To determine
whether this phosphorylation was specific to our cell line or common to human NK cells,
we evaluated the phosphorylation of myosin IIA from human eNK cells, as well as in
eNK cell lytic granules. In eNK cells and granules, myosin IIA was also phosphorylated
at S1943 (Figure 3.4E), suggesting that regulation of myosin observed in NK cell lines is
similar to that in primary human NK cells, and that the MYH9 tailpiece was required for
its phosphorylation.
Phosphorylation of myosin IIA at Ser1943 is required for NK cell cytotoxicity.
Since we found that S1943 is phosphorylated in NK cells, and that cells expressing
truncated myosin IIA lacking this residue (1933x) were impaired in cytotoxic activity, we
wanted to determine if there was a specific requirement for S1943 phosphorylation in NK
cell function. Thus, we generated a YTS cell line expressing GFP-tagged myosin IIA
with an S1943A mutation, which would therefore be unphosphorylatable at residue 1943
(YTS-S1943A-GFP).
These cells expressed GFP-tagged S1943A myosin IIA at approximately 20% of
endogenous myosin levels, similar to MyoIIA-GFP and 1933x-GFP cells (Figure 3.2).
The YTS-S1943A-GFP cells, however, had reduced levels of cytotoxicity compared to
both MyoIIA-GFP and 1933x-GFP cells (Figure 3.5A-B). This reduction in cytotoxic
bands: the larger corresponds to 253 kDa and represents the myosin IIA GFP fusion; the smaller
corresponds to 227 kDa and represents the endogenous myosin IIA. The inclusion of 2 heavy
chains in each myosin hexamer enables association of exogenous and endogenously expressed
myosin IIA molecules when evaluated via immunoprecipitation (see also Figure 3.2). Results
are representative of three (A-E, eNK) or two (E, LG) independent assays.
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activity of S1943A-GFP cells was present in both one and four hour assays, although
S1943A-GFP cells demonstrated detectable cytotoxic activity at four hours. The
reduced killing in these cells was not due to impaired viability, as all cell lines were >95%
viable by flow cytometry for Annexin V and 7AAD (not shown). Additionally, the YTSS1943A-GFP cells were as capable of conjugating to 721.221 target cells as MyoIIAGFP and 1933x-GFP cells (Figure 3.6A), and also secreted IFN-γ at similar levels upon
conjugation (Figure 3.5C), suggesting that other effector functions requiring NK cell
activation were intact. Compared to YTS-MyoIIA-GFP, S1943A-GFP cells demonstrated
reduced phosphorylation of the GFP-tagged protein in GFP immunoprecipitates (Figure
3.7). This effect was similar to that in the 1933x-GFP expressing cells. These results

Figure 3.5. Myosin IIA phosphorylation at Ser1943 is required for NK cell
cytotoxicity, but not IFN-γγ secretion.
Cytotoxic activity (A-B) and IFN-γ secretion (C) of YTS cells expressing wild-type myosin IIAGFP (YTS-MyoIIA-GFP), 1933x myosin IIA-GFP (YTS-1933x-GFP), or S1943A myosin IIAGFP (YTS-S1943A-GFP) was measured against 721.221 target cells. Cytotoxicity was
51
measured at at 1h (A) and 4h (B) after conjugation by Cr-release assay. (C) IFN-γ secretion
into supernatant was measured 24h after conjugation by ELISA and calculated by subtracting
IFN-γ secretion of NK cells alone. In all experiments, results are the mean of three
independent assays and error bars indicate SD.
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suggest that Ser1943 is a primary site for phosphorylation in myosin IIA, which is
specifically required for NK cell cytotoxicity.
Ser1943 phosphorylation mediates the interaction of myosin IIA with lytic
granules.
In order to determine the mechanism of the impact of S1943A-GFP myosin expression
on NK cell killing, we examined conjugates of YTS-MyoIIA-GFP, 1933x-GFP, and
S1943A-GFP NK cells with 721.221 target cells using immunofluorescence confocal
microscopy. Compared to the YTS-MyoIIA-GFP cells, 1933x-GFP and S1943A-GFP
cells formed equally mature synapses with target cells, with polymerization of F-actin at
the IS and polarization of GFP-tagged myosin to the region of F-actin accumulation
(Figure 3.8A). While perforin also polarized to the IS in cells expressing the mutant
myosins, colocalization of perforin fluorescence with GFP fluorescence was diminished
in 1933x-GFP and S1943A-GFP cells compared to YTS-MyoIIA-GFP (Figure 3.8B,
42.05% perforin volume colocalized with GFP in MyoIIA-GFP, vs. 20.77% and 20.15% in
1933x- and S1943A-GFP). This suggests that that the mutant myosin molecules were
less capable of associating with NK cell lytic granules. The ability of the GFP-tagged

Figure 3.6. Expression of myosin IIA mutants does not affect conjugation with
target cells.
YTS cells expressing wild-type myosin IIA-GFP (MIIA-GFP), 1933x myosin IIA-GFP (1933xGFP), or S1943A myosin IIA-GFP (S1943A-GFP) were allowed to conjugate to PKH26 dyeloaded 721.221 target cells for 30 minutes. Conjugation was evaluated by flow cytometry and
+
is depicted as percent of total GFP NK cells in conjugate. Results are representative of three
independent assays.
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Figure 3.7. Ser1943 is a major site of phosphorylation in myosin IIA.
GFP-tagged proteins were immunoprecipitated from lysates from YTS cells or YTS cells
expressing wild-type myosin IIA-GFP (MIIA), S1943A myosin IIA-GFP (S1943A), or 1933x
myosin IIA-GFP (1933x). GFP immunoprecipitates were evaluated by gel stain for total
phosphorylation (Pro-Q) and total protein (Sypro). The larger of the two bands represents
the myosin IIA-GFP fusion and the smaller the endogenous myosin IIA. Results are
representative of three independent experiments.

myosin mutants to associate with lytic granules was evaluated using Western blot
analysis of isolated lytic granules from YTS-MyoIIA-GFP, 1933x-GFP, and S1943A-GFP
cells. Compared to YTS-MyoIIA-GFP cells, the GFP signal as a feature of total granule
protein, as well as the detectable myosin IIA, was reduced in granules from 1933x-GFP
and S1943A-GFP cells (Figure 6C), indicating that the association of the myosin mutants
with lytic granules is reduced. Overall, these data suggest that an intact myosin IIA
tailpiece and phosphorylation of myosin IIA are required for association with lytic
granules.
Myosin IIA associates with lytic granules in single-molecule form via the tailpiece.
Because phosphorylation of myosin IIA via its tailpiece was required for its linkage to
lytic granules, we sought to determine whether myosin IIA associates with granules via
the tailpiece directly. Although many myosin classes are known to associate with cargo
in single-molecule form, using the tail for cargo binding (Akhmanova and Hammer,
2010), myosin II family members are typically considered to exist in filaments. To
determine the mechanism of myosin IIA association with lytic granules, granules were
isolated from YTS NK cells and prepared for platinum rotary shadowing electron
microscopy (EM), a technique that highlights three-dimensional structures (Svitkina,
2009). The lytic granules, which were adhered to glass coated with anti-myosin IIA
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Figure 3.8. The myosin IIA tailpiece and S1943 phosphorylation are required for
its interaction with lytic granules.
(A) Confocal fluorescent micrographs of YTS cells expressing wild-type myosin IIA-GFP
(MyoIIA-GFP), 1933x myosin IIA-GFP (1933x-GFP), or S1943A myosin IIA-GFP (S1943AGFP) conjugated to 721.221 target cells (721). Differential interference contrast (DIC, left) in
addition to fluorescent signal for actin (red), perforin (blue), GFP-myosin (green) are shown
along with an overlay of fluorescent channels (right). Scale bar, 5 µm. (B) Percent of total
perforin fluorescent volume colocalized with GFP volume +SD. >20 cells per condition were
analyzed. (C) Western blot of isolated lytic granules from resting YTS cells or YTS cells
expressing wild-type myosin IIA-GFP (MIIA), 1933x myosin IIA-GFP (1933x), or S1943A
myosin IIA-GFP (S1943A). GFP, myosin IIA, and granzyme B (GzmB) blots are shown.
Imaging and analysis were performed with the assistance of Emily Mace.
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antibody, demonstrated emanating structures with an appearance and dimensions
characteristic of myosin IIA molecules (Figure 3.9A). The lytic granules measured an
average of 420 nm in diameter, consistent with estimates of lytic granule size. Similarly,
the long, rod-like domains of the associated structures had a mean length of 194 nm,
consistent with the length of the myosin IIA rod domain (Fath, 2005). To verify that the
molecules present around the periphery of the lytic granules were myosin IIA and to gain
greater insight into their arrangement, isolated granules were evaluated in ultraresolution using stimulated emission depletion (STED) microscopy (Huang et al., 2010).
Our images had a resolution of 54 nm, as determined by measuring single fluorophoreconjugated antibody signal (not shown). If myosin IIA associated with NK cell lytic
granules in filamentous form, the distance between tailpiece regions of adjacent
molecules would be expected to be a consistent 14.3 nm, equivalent to the stagger of
myosin IIA molecules in filaments (Straussman et al., 2005), which would appear as a
continuous string of myosin IIA signal surrounding the granule at 54 nm resolution. In
contrast to this prediction, isolated lytic granules labeled with an antibody against the
myosin IIA tailpiece demonstrated a distance of approximately 73-380 nm between
myosin molecules (Figure 3.9B-C), with a mean of 179.8 nm over three images.
Furthermore, the distance between molecules was irregular (standard deviation of 86 nm
in distance between molecules), making a large ordered complex of myosin IIA
molecules unlikely. Taken together, these results suggest an association of single
irregularly spaced molecules of myosin IIA with lytic granules via the tailpiece. They
more broadly define a mechanism by which a prefinal step for human NK cell cytotoxicity
is governed through the tail-dependent phosphorylation and function of lytic granuleassociated myosin IIA, which claims granules as cargo.
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Figure 3.9. Single molecules of myosin IIA associate with NK cell lytic granules.
Lytic granules were isolated from resting YTS cells and evaluated by platinum rotary
shadowing EM (A) and STED microscopy (B-C). (A) YTS cell lytic granule with emanating
structures resembling myosin IIA, which are highlighted in color in the image at right. Scale
bar, 200 nm. (B) YTS cell lytic granule visualized with an antibody against the myosin IIA
tailpiece (green, left). The distance between myosin IIA antibody molecules was measured
using a line drawn around the periphery of the lytic granules (white, right). Scale bar, 500 nm.
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Discussion
Previously, we demonstrated that myosin IIA is associated with NK cell lytic granules
and facilitates the interaction of granules with F-actin at the IS for exocytosis (Sanborn et
al., 2009). This role for myosin IIA required its motor function and tailpiece, yet the
mechanism for the association of myosin with the granules was unclear. We sought to
further examine the role for myosin IIA in NK cell lytic granule exocytosis by determining
which portions of the protein are required for NK cell cytotoxicity. Studies of NK cells
from patients with mutations in MYH9 point to a requirement for the motor function and
tailpiece, as rod mutations in MYH9 had a lesser effect on NK cell cytotoxicity (Figure
3.1). Because the rod domain is important for regulating intermolecular interactions
during filament formation (Ricketson et al., 2010), and at least one of the mutations
examined has been shown to alter the periodicity of myosin IIA rods (D1424N (Franke et
al., 2005)), these results suggest that the ability to form bipolar filaments is not required
for this function of myosin IIA. These data provide a clinical relevance to the role of
myosin IIA in NK cell killing, and raise an additional consideration in patients with MYH9RD.
While the requirement for the motor domain of myosin IIA in lytic granule exocytosis
was likely due to the need to translocate granules across actin filaments (Sanborn et al.,
2009), the role of the nonhelical tailpiece was less clear. Unlike the 1933x truncation
mutation, which removes the entire tailpiece of myosin IIA, a greater portion of the
tailpiece remains intact in the 5779delC myosin, which also affected NK cell killing
(C) Normalized intensity plot along the line drawn at the periphery of the lytic granule shown
in (B). Numbers at top indicate the distance between adjacent antibody molecules. Results
are representative of >10 (A) or 3 (B-C) images. (D) Proposed model of myosin IIA
interaction with NK cell lytic granules. Unphosphorylated myosin IIA tailpiece obscures the
binding site for lytic granules (highlighted in turquoise). Myosin IIA tailpiece phosphorylated
at S1943 bends backward onto the rod, revealing the putative granule binding site. 1933x
myosin IIA is missing a large portion of the granule binding site, and therefore can not sustain
an interaction with granules under force. S1943A myosin IIA has an intact tailpiece but
cannot be phosphorylated, and therefore cannot reveal its putative granule binding site.

72

(Figure 3.1). This also leads to a truncation (Kunishima et al., 2001a), albeit smaller,
and suggests that the requirement for the tailpiece may be a feature of the amino acid
sequence rather than related to tail or filament structure. In this light, the C-terminus of
myosin IIA is a key site of phosphorylation in many cell types, including mast cells
(Ludowyke et al., 2006) and human T cells (Jacobelli et al., 2004). In order to
understand the importance of regulation via the myosin IIA tailpiece, we created a YTS
NK cell line expressing GFP-tagged 1933x myosin, which demonstrated a cytotoxicity
defect only at early time points (Figure 3.3). This may be due to the presence of
sufficient endogenous myosin IIA, however, it is also possible that the 1933x myosin is
capable of associating weakly with the lytic granules, allowing it to partially assist in
granule exocytosis as discussed below. In attempting to gain greater insight, we
observed that the mutant myosin from YTS-1933x-GFP cells or lytic granules prepared
from these cells demonstrated reduced phosphorylation (Figure 3.4), suggesting that the
tailpiece of myosin IIA is required for phosphorylation of the entire protein. This is due to
the phosphorylation of S1943, as this site was phosphorylated in wild-type myosin IIA
and is absent in the truncated 1933x protein. We also found that S1943 was
phosphorylated in ex vivo human NK cells (Figure 3.4E), indicating that this mechanism
of regulation is not exclusive to our cell line. When we evaluated the role of this residue
specifically, we found that S1943A myosin-expressing cells formed conjugates with
target cells and secreted IFN-γ adequately, but had diminished cytotoxicity, suggesting
S1943 phosphorylation directly regulates the function of myosin IIA in lytic granule
exocytosis
Since mutations of the rod domain of myosin IIA, which regulates filament formation,
did not affect NK cell cytotoxicity (Figure 3.1), the requirement for the MYH9 tailpiece
suggested that it may directly mediate granule attachment using a S1943
phosphorylation dependent mechanism. This is based upon our observation that cells
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expressing S1943A-GFP myosin demonstrated reduced cytotoxicity and association of
the GFP-tagged myosin with perforin-containing granules (Figures 3.5 and 3.8). Images
of lytic granules using two different ultra-resolution techniques suggested that myosin IIA
is attached to NK cell lytic granules via its tail, as best visualized using platinum rotary
EM, and is not present in large radial filaments, as determined by irregularly spaced
fluorescent signal in STED imaging (Figure 3.9). Although the STED images do not
exclude the possibility that myosin IIA could exist in clusters or microfilaments on the
granules, the large, irregular spacing of the molecules suggests that an association of
large myosin filaments with lytic granules is unlikely. To our knowledge, this work
represents the first use of STED in for ultra-resolution evaluation of NK cell components.
In light of these observations, we propose a model for the interaction of myosin IIA
with NK cell lytic granules (Figure 3.9D). S1943 phosphorylation by casein kinase II has
been suggested to cause the myosin IIA nonhelical tailpiece to bend back onto the Cterminal portion of the rod domain, thus downregulating its ability to form filaments
(Dulyaninova et al., 2005). Since the tailpiece is also the location of lytic granule
binding, in NK cells Ser1943 phosphorylation could additionally expose a binding site for
lytic granules that is unavailable in the unphosphorylated protein. Therefore, constitutive
phosphorylation of a pool of myosin IIA at Ser1943 would ensure that myosin IIA could
interact with lytic granules. In the case of the 1933x mutation, the truncated tailpiece
may allow for weak binding of myosin IIA to lytic granules, however, this weak
association would not enable myosin IIA to direct the motility of lytic granules across
densely packed actin filaments at the IS. Because the truncated myosin molecules
could bind to both actin and the granules, however, they may act to stabilize the
granules at the surface of actin, allowing for them to eventually reach the plasma
membrane in the presence of sufficient wild-type myosin IIA, such as in the YTS-1933xGFP cells. In the case of the S1943A point mutation, however, an unphosphorylatable
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myosin tailpiece would remain in a conformation in which the binding site for lytic
granules was obscured. This would prevent any interaction with the lytic granules,
potentially even in myosin IIA molecules in which one heavy chain is wild-type and the
other is mutated. This mechanism would explain our observed greater reduction in
cytotoxicity in the YTS-S1943A-GFP cells compared to the 1933x-GFP cells, as the lytic
granules in the former would be less capable of stably interacting with actin.
While interacting with organelles in a single-molecule conformation represents an
unconventional role for myosin IIA, previous reports have suggested a similar
mechanism in other systems. An interaction of myosin II with secretory vesicles has
been demonstrated in diverse cell types (Seabrooke et al., 2010). Furthermore, in clam
oocyte extracts and Drosophila neurons, inhibition of myosin II activity reduces the
motility of vesicles along actin (DePina et al., 2007), suggesting that myosin II can direct
the motility of vesicles as cargo along actin filaments. Although myosin IIA is not
conventionally thought to be a processive motor, a recent study has suggested that
myosin IIB may be processive across short distances (Norstrom et al., 2010), and thus, it
is possible that once lytic granules are delivered to the IS, myosin IIA could direct the
motility of lytic granules across short stretches of actin to the plasma membrane.
Additionally, motor molecules that lack processivity as a single unit can still direct
processive motion of cargo, provided that enough motors exist on the cargo that at least
one is in contact with the track at all times (Gross et al., 2007). Our data indicate that
multiple myosin IIA molecules exist on each lytic granule (Figure 3.9A-C), and therefore
the cooperation of these molecules may be sufficient to direct lytic granules across actin
at the IS. While the specific linkage between individual myosin IIA molecules and
granules requires further study, the present results define a new role for myosin IIA in
the immune system and in governing NK cell function, specifically that single molecule
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tail-based associations to granules and myosin IIA tail phosphorylation are essential for
accessing NK cell cytotoxicity.
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Chapter 4: Discussion4
Summary
NK cell cytotoxicity represents an important line of defense against infected and
transformed cells, but this ability to kill other cells is, by necessity, tightly regulated. An
NK cell preparing to lyse a target cell must proceed through a series of steps, beginning
with the initial ligation of tethering and adhesion receptors and ending with the secretion
of lytic granule contents (Reviewed in Chapter 1 and (Orange, 2008)). These steps are
critically important to NK cell function, as NK cell functional deficiencies are reported in
patients with mutations in proteins that are involved in each step (Orange, 2006).
In Chapter 2, we define a functional association of nonmuscle myosin IIA with lytic
granules in NK cells. We demonstrate that this association is critical to a final step of NK
cell cytotoxicity, where lytic granules must travel through F-actin gathered at the IS to
facilitate secretion of granule contents at the plasma membrane. Myosin IIA motor
function is required for the interaction of lytic granules with F-actin, suggesting that once
polarized to the NK cell IS, lytic granules traverse the F-actin cortex using associated
myosin IIA. We also demonstrate a requirement for the nonhelical tailpiece of myosin
IIA, as NK cells from patients with the 1933x truncation mutation in myosin IIA have
reduced cytolytic function. While the 1933x mutation does not prevent association with
lytic granules, the granules are unable to interact with F-actin, thus implicating the
nonhelical tailpiece of myosin IIA, in addition to its ATPase activity, in the interaction of
lytic granules with F-actin.
4

Part of this chapter has been published as:

Sanborn KB, Orange JS.
Navigating Barriers: the challenge of directed secretion at the natural killer cell lytic immunological
synapse.
Journal of Clinical Immunology. May 2010; Volume 30, pp.358-363.
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In Chapter 3, we further explore the requirement for each functional domain of
myosin IIA. We find that the head and S2 regions, as well as the tailpiece, are required
for the function of myosin IIA in NK cell degranulation, while the rod domain is less
important, suggesting that filament formation is not critical to this role for myosin IIA. We
demonstrate that myosin IIA associates with NK cell lytic granules in single-molecule
form rather than in filaments, and that this interaction is regulated by phosphorylation of
the nonhelical tailpiece at Ser1943. This represents a novel mechanism of myosin IIA
function in facilitating secretion.
Several questions remain regarding this role for myosin IIA and the nature of this
step in the cytotoxic process. In this chapter, I discuss the significance of our findings
and potential areas of future research.

Nature of myosin IIA association with lytic granules
We have demonstrated that myosin IIA associates with NK cell lytic granules to
facilitate their transport through F-actin at the IS (Chapter 2). This association requires
the nonhelical tailpiece of myosin IIA, and is regulated by phosphorylation of the tailpiece
at Ser1943 (Chapter 3). The interaction of single molecules of myosin IIA with secretory
vesicles as cargo is a novel finding, and therefore the precise nature of this association
remains unclear. Although the protein has been shown to localize to the outer
membrane of lytic granules (Chapters 2 & 3), it is not known whether this association
with the membrane is direct, or whether myosin IIA interacts with other proteins on the
granule membrane. Myosin IIA is capable of interacting directly with phosphatidylserinecontaining membranes (Li et al., 1994; Murakami et al., 1994), and therefore could
potentially associate with lytic granules directly. As the C-terminus is required for the
association with membranes, this could explain the requirement of the nonhelical
tailpiece for a strong association of myosin IIA with lytic granules. Alternatively, myosin
IIA may associate with lytic granules in an indirect fashion, via an interaction with
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granule membrane-associated proteins. This could be similar to the association of
myosin V with melanosome membranes via a complex of rab27a and melanophilin (Wu
et al., 2006). Although this is perhaps a more likely mechanism of interaction with lytic
granules, there are few proteins which have been characterized to interact with the Cterminus of myosin IIA, other than the kinases PKC and CKII (Dulyaninova et al., 2005).
Myosin IIA has been found in a complex with the actin-interacting proteins WIP and
WASp in NK cells (Krzewski et al., 2006), and since WIP has been identified in NK cell
lytic granule preparations (Krzewski et al., 2008), it is possible that the association of
myosin IIA with lytic granules occurs through this complex. Further studies of interaction
partners for myosin IIA may provide additional information about how myosin interacts
with NK cell lytic granules.

Additional regulation of myosin IIA in NK cells
We have found that myosin IIA is constitutively associated with NK cell lytic granules,
rather than being recruited to granules at the IS (Chapter 2). This constitutive
association suggests that additional regulation must occur in order for myosin IIA
function to be confined to the IS. Although myosin IIA is regulated by phosphorylation at
Ser1943 to ensure a functional association with lytic granules (Chapter 3), since this
phosphorylation is constitutive, and myosin IIA heavy chain lacking this residue
(S1943A) has greatly reduced phosphorylation compared to wild-type myosin IIA, it is
unlikely that any additional heavy chain phosphorylation of lytic granule-associated
myosin IIA occurs specifically at the IS. Thus, the function of myosin IIA in degranulation
is likely to be regulated by light chain phosphorylation or by interaction with proteins
specifically localized at the IS.
The motor activity of myosin IIA is heavily regulated by phosphorylation of its
regulatory light chains. Phosphorylation of the light chains at Ser19 generally increases
the ATPase activity of myosin IIA, while phosphorylation at Ser1 and Ser2
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downregulates its affinity for actin ((Adelstein and Conti, 1975; Nishikawa et al., 1984),
reviewed in (Sellers, 1999)). Thus, as myosin IIA activity would need to be selectively
increased once lytic granules reach the NK cell IS, one could envision a scenario in
which light chains are phosphorylated at Ser1/2 to downregulate myosin activity prior to
granules reaching the IS, then dephosphorylated to increase the affinity of granuleassociated myosin for actin at the IS. Alternatively, myosin IIA phosphorylation at Ser19
could be downregulated by MYPT in resting cells, and the residue could be inducibly
phosphorylated to promote myosin activity once lytic granules reach cortical F-actin.
Both mechanisms may have a role in regulating granule-associated myosin IIA, and
further studies focusing on the myosin IIA light chains may provide additional insight into
regulation of lytic granule exocytosis.
In addition to regulation of the myosin IIA light chains, myosin IIA function may be
facilitated by its interaction with proteins located at the IS. Myosin IIA has been shown
to interact with a complex of WIP and WASp at the IS in activated NK cells (Krzewski et
al., 2006). Because WIP and WASp are involved in F-actin reorganization, this
interaction could potentially facilitate the transport of lytic granules across actin by
stabilizing the interaction of the granules with F-actin at the IS. Alternatively, if granuleassociated myosin IIA is involved in forming small conduits in actin for the lytic granules
(see next section), the interaction with actin-regulating proteins could enable remodeling
of F-actin for conduit creation.
Another protein that may be involved in the regulation of myosin IIA is mts1/S100A4.
Because mts1 binds to the tailpiece of myosin IIA, and can regulate phosphorylation
status, an interaction with mts1 could determine whether myosin IIA is capable of
binding to lytic granules. Since granule-associated myosin IIA is phosphorylated at
Ser1943 (Chapter 3), and Ser1943 phosphorylation downregulates the binding of mts1
to myosin IIA (Dulyaninova et al., 2005), mts1 could potentially negatively regulate the
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association of myosin with lytic granules. This could be critical during the refractory
period following target cell lysis, when lytic granule membrane must be recycled to
create new granules for future cytotoxic activity. Additionally, although the interaction of
mts1 with myosin IIA has been demonstrated to regulate filament formation (Ford et al.,
1997; Li et al., 2003; Malashkevich et al., 2008), since its binding site in the tailpiece is
near the region needed for interaction with lytic granules, it could potentially modulate
the binding of myosin IIA to granule-associated proteins as well. This could be a
negative regulation, if mts1 competes for a binding site with other proteins, or its
presence at the start of the nonhelical tailpiece could also facilitate the interaction of
myosin IIA with a granule-associated protein. It is unlikely that mts1 binds directly to lytic
granules, however, and therefore this would represent an additional layer of myosin
regulation, not a mechanism of interaction with granules. Further examination of the role
of mts1 and other myosin-interacting proteins in NK cell degranulation could potentially
uncover additional mechanisms of myosin IIA regulation.

Role of F-actin at the IS and mechanisms of myosin IIA function in
secretion
The role for myosin IIA in facilitating the interaction of lytic granules with F-actin for
NK cell degranulation suggests that NK cells require actin-based motor function for the
transport of lytic granules across F-actin. The nature of this requirement, however,
depends largely upon whether NK cells secrete lytic granule contents through large actin
clearances or through smaller conduits in the actin network. Lytic granule exocytosis in
CTLs and NK cells has traditionally been thought to occur at F-actin-depleted regions. If
large clearances in actin are, indeed, the location of secretion for lytic granule contents,
it remains unclear whether lytic granules are delivered directly to these clearances, or
whether they must travel along actin filaments at the IS to reach an actin-sparse region
in which they might reach the plasma membrane. A recent study has shown that in
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CD4+ CTLs, lytic granules are initially delivered to the pSMAC region, while secretion of
their contents occurs in the cSMAC (Beal et al., 2009). The study did not elucidate the
mechanism of transporting granules from the pSMAC to the cSMAC, and therefore it is
unclear whether the movement requires travel along actin filaments or whether it is
entirely microtubule-based. While delivery of granules to the pSMAC has not been
demonstrated in NK cells, in T cells, signal strength has been shown to play a role in
which method of transport lytic granules use to reach the IS (Beal et al., 2009; Jenkins et
al., 2009). The strength of activation signaling vs. inhibitory signaling could therefore
determine whether NK cell lytic granules are secreted in a region that is replete or
relatively devoid of F-actin. If granules do, in fact, reach the membrane through actinfree regions at the cSMAC, myosin IIA may have a role in the movement of lytic granules
from the actin-dense pSMAC to large clearances at the cSMAC, allowing for the lytic
granules to reach the plasma membrane upon reaching an actin clearance.
While large clearances in F-actin have been demonstrated in NK cells (Andzelm et
al., 2007; Orange et al., 2003; Roda-Navarro et al., 2004; Vyas et al., 2001), and could
be the location of directed secretion of granule contents, it remains unclear whether all
F-actin at the IS is cleared away for secretion. Recent data from our laboratory
demonstrate that while the actin network is less dense at the center of the IS, filaments
remain dense enough to present a barrier to secretion of granule contents (Gregory D.
Rak, Tatyana Svitkina, and Jordan S. Orange, submitted). This suggests that lytic
granules are more likely to travel through smaller F-actin conduits rather than to be
delivered directly to the plasma membrane at a large clearance in actin. If lytic granules
use smaller actin conduits rather than the cSMAC for secretion, the requirement for
myosin IIA may be in directing the granules through these conduits. Another possibility
is that lytic granule-associated myosin IIA is directly involved in the creation of the actin
conduits themselves. Large-scale remodeling of actin at the IS in NK cells treated with
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blebbistatin was normal (Andzelm et al., 2007), however, if myosin IIA is required for the
creation or enlargement of small actin conduits, this could represent a novel function for
this actin-based motor.
The physical challenge of the transit of a lytic granule of approximately 500 nm in
size through the cell cortex is one which must, by necessity, require a solution. The
process may utilize different mechanisms at different points during IS formation, at least
some of which are likely to involve significant interaction with actin filaments. Defining
the precise function of myosin IIA in this process will likely require advanced imaging
techniques, given the small size of the structures in question. Further studies defining
how lytic granules interact with F-actin will additionally clarify the role of actin-interacting
and actin motor proteins in NK cell granule localization and degranulation.

Requirement for myosin IIA in T cell vs. NK cell cytotoxicity
We have demonstrated a role for myosin IIA in facilitating lytic granule exocytosis for
NK cell cytotoxicity (Chapters 2 and 3). While myosin IIA has been shown to interact
with NK cell lytic granules, it is unknown whether this interaction occurs in CTLs as well.
Because their primary effector functions require exocytosis of lytic granules for target cell
lysis, CTLs and NK cells are typically thought to use similar mechanisms to secrete
granule contents. This may not be correct however, as NK cells are innate immune
lymphocytes and T cells are antigen-specific adaptive immune cells, and their signaling
requirements differ. Differences in MTOC and lytic granule polarization have also been
noted between the two cell types, as T cells have been shown to use signal strengthdependent mechanisms of granule trafficking (Beal et al., 2009; Jenkins et al., 2009) and
NK cell granules have been demonstrated to converge to the MTOC early on in the
signaling process (Mentlik et al., 2010). Furthermore, additional roles for myosin IIA
have been defined in T cells that do not necessarily apply to T cells. For instance,
myosin IIA has a well-defined role in the regulation of T cell motility, migration, and IS
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stability (Ilani et al., 2009; Jacobelli et al., 2009; Jacobelli et al., 2004; Jacobelli et al.,
2010). Although these studies were primarily performed in CD4+ T cells, CD8+ T cells
are expected to be similar (Jacobelli et al., 2010). In contrast, although their migration
has not been directly evaluated, NK cells treated with myosin II inhibitors or myosin IIA
siRNA are capable of productive conjugation with target cells; can polarize actin,
receptors, and perforin to the IS; and can secrete IFN-γ. This suggests that T cell and
NK cell IS formation may be differentially regulated, and therefore lytic granule
exocytosis may occur through different mechanisms as well. Evaluating the steps of the
cytolytic process in T cells and NK cells may uncover unanticipated differences in how
innate and adaptive cytotoxic lymphocytes are regulated.

Implications for patients with MYH9-RD
We have defined a deficiency in NK cell cytolytic function in patients with MYH9-RD
(Chapter 3). As with several other symptoms of MYH9-RD, mutations in certain regions
of the protein, in particular regions affecting motor function or the tailpiece, have a more
substantial effect on NK cell cytotoxicity, suggesting that these regions are most
important for the function of myosin IIA in NK cells.
Although several MYH9-RD patients have demonstrated reduced NK cell
cytotoxicity, the patients we have evaluated generally do not experience rare or chronic
viral infections (Table 1), as most patients with NK cell deficiencies do (Orange, 2006).
While one patient with a 1933x mutation in myosin IIA experienced infection with
Listeria, and another had Hepatitis C infection following a platelet transfusion, most
patients remain immunologically competent. It is unclear why these patients appear to
be capable of fighting infections normally even though their NK cells do not have normal
cytolytic capacity in vitro. We have informally observed higher NK cell percentages in
most MYH9-RD patients compared to controls, although these numbers remain in the
normal range. Combined with the fact that NK cell function is not entirely absent in the
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patients, a slightly elevated NK percentage could account for the normal immune
function in these patients. Alternatively, it is possible that additional activation
mechanisms could compensate for myosin-related effects in vivo.
Mutations in MYH9 are extremely rare, and therefore it is difficult to determine
whether MYH9-RD has enough potential to affect NK cell activity to be considered a
classical immune deficiency. Nonetheless, although most of the patients we have
evaluated have not experienced severe infections, the reduction in NK cell cytolytic
function in patients with MYH9 mutations suggests that patients with MYH9-RD may be
more susceptible to infections that require NK cell cytolytic function for defense. This
increased potential for serious infection should be considered by physicians when
evaluating patients with MYH9-RD.

Conclusions
This work has demonstrated a role for nonmuscle myosin IIA in NK cell lytic granulemediated cytotoxicity. We have shown that myosin IIA constitutively associates with lytic
granules to facilitate their interaction with F-actin at the NK cell IS. This interaction is
required for the exocytosis of lytic granule contents, and therefore represents an
additional important step in directing target cell lysis. Furthermore, we have
demonstrated that single molecules of myosin IIA interact with lytic granules via their Cterminal nonhelical tailpiece, and that this interaction requires phosphorylation of the
tailpiece at residue Ser1943. This represents a novel mechanism for myosin IIA in the
transport of secretory vesicles. Together, these results demonstrate that NK cells utilize
an unconventional method of actin-based transport, whereby myosin IIA directs transport
of lytic granules as cargo across F-actin to the plasma membrane for secretion.
Further studies of the series of steps involved in the cytotoxic process will be
instrumental to our understanding of how NK cells are able to kill their targets. The
relationship of lytic granules with the MTOC and their ability to navigate F-actin
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clearances once they reach the IS remain important areas of investigation. Future
studies of the role of myosin IIA in directing lytic granule exocytosis will focus on the
precise nature of the association with lytic granules, additional regulation of granuleassociated myosin IIA, and the very nature of the clearances that allow for myosindependent secretion of granule contents. Understanding the steps that lead up to the
directed secretion of lytic granule contents will allow for the possibility of restraining or
augmenting NK cell function.

86

Chapter 5: Materials and Methods
Cells
Blood samples and ex vivo NK cell preparation.
PBMCs were prepared from whole blood obtained from patients or healthy volunteer
donors using centrifugation through Ficoll-Paque Plus lymphocyte isolation medium
(Amersham Biosciences). For Chapter 2, ex vivo NK (eNK) cells were prepared from
PBMCs either by negative selection as described (Banerjee et al., 2007), or by FACS for
CD56+CD3- lymphocytes in the cell sorting facility of Children’s Hospital of Philadelphia
using a BD FACSVantage SE/DiVa cell sorter (BD Biosciences), and were used in
experiments immediately after preparation. To expand eNK cells for granule preparation,
isolated CD56+CD3- NK cells were co-cultured with irradiated allogeneic PBMCs and
RPMI 8866 cells in RPMI 1640 media (Gibco) containing 5% human serum (Atlanta
Biologicals), 500 U/mL human recombinant IL-2 (NIH AIDS Research and Reference
Reagent Program), 5 x 10-5 M 2-mercaptoethanol (Gibco), and 2 µg/mL
phytohemagluttinin (PHA, Sigma Aldrich). Following establishment of the culture,
additional irradiated allogeneic PBMCs and RPMI 8866 cells were added along with 2
µg/mL PHA every 21-30 days and expanded NK cells were monitored over time to
maintain near 90% NK cell purity. For Chapter 3, eNK cells were prepared from whole
blood by negative selection using RosetteSep human NK cell enrichment cocktail
(Stemcell Technologies). For experiments biochemically evaluating eNK cells and lytic
granules, eNK cells were prepared as described above from apheresis product obtained
from individuals with hemoglobinopathy, which does not substantially alter NK cell
granule content (data not shown). For samples from patients with MYH9-related
diseases, mutation analyses were performed at Duke University, Mount Sinai School of
Medicine, the Children’s Hospital of Philadelphia according to published methods (Kelley
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et al., 2000). All human samples were obtained with informed donor consent and were
used with the approval of the institutional internal review board for the protection of
human subjects at the Children’s Hospital of Philadelphia.
Cell lines.
The immortalized NK cell lines YTS as well as YTS stably expressing GFP (YTSGFP), or one of three different myosin IIA-GFP fusion proteins: full length (YTS-MyoIIAGFP), 1933 truncated (YTS-1933x-GFP) or S1943A mutant (YTS-S1943A-GFP), were
used as model NK cell systems and are described elsewhere (Banerjee et al., 2007) or
generated as described below. 721.221 EBV-transformed B-lymphoblastoid cells, K562
erythroleukemia cells, and K562 cells stably expressing CD86 (KT86, previously used
and described (Banerjee et al., 2007)) were used as target cells.
To generate YTS-MyoIIA-GFP cells, 3 x 106 YTS cells were nucleofected using an
Amaxa Nucleofector (Amaxa, Inc.) with 2 µg of linearized GFP-human nonmuscle
myosin IIA heavy chain plasmid containing a neomycin resistance gene (Addgene) in
Amaxa solution R (Amaxa Inc.), using nucleofection program O-017. Transfected cells
were selected in G418 sulfate (Cellgro) and repeatedly sorted by FACS to obtain a pure
population of GFP-expressing cells. For the creation of MYH9-1933x-GFP and MYH9S1943A-GFP constructs, plasmid DNA encoding GFP-human nonmuscle myosin IIA
heavy chain, described above, was modified to contain C5797T (1933x) or T5827G
(S1943A) alterations in the coding region of the MYH9 gene. Cell lines were created by
nucleofection as described above.
Flow cytometric, conjugation, and degranulation analyses.
eNK cells from patients, healthy volunteer donors, or apheresis donors were
analyzed for expression of CD56 and CD3 using fluorophore-conjugated mAbs (BD
Biosciences). All ex vivo NK cell samples from whole blood used contained a mean
purity of >72% CD56+CD3- cells. YTS NK cell lines were analyzed for expression of
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GFP, as well as for viability by staining with Annexin V-PE and 7AAD (BD Biosciences).
YTS and eNK cell granzyme B and perforin content was evaluated by intracellular flow
cytometry using fluorophore-conjugated mAbs (BD Biosciences).
For analysis of NK cell degranulation in Chapter 2, PBMCs were resuspended at a
concentration of 1 x 106 cells/mL to which 1 x 105 K562 cells, 3µg/mL anti-CD28 and
anti-CD49d (BD Biosciences), 0.7 µg/mL monensin (BD Biosciences), 1 µg/mL brefeldin
A (Sigma-Aldrich) and anti-CD107a were added. Cells were incubated at 37˚C, 5% CO2
for 5h, washed, stained for viability with Aqua amine-reactive viability dye (Invitrogen),
and then stained with surface antibodies. K562 were not added to control samples.
Antibodies for surface staining included anti-CD4 PE-Cy5-5 (Invitrogen) or PerCP-Cy5.5
(BD Biosciences), anti-CD56 PE (BD Biosciences) and anti-CD107a FITC (BD
Biosciences). The cells were then washed and permeabilized using the
Cytofix/Cytoperm kit (BD Biosciences) according to the manufacturer's instructions and
stained with anti-CD3 Qdot 585 for 1 hour, washed, and fixed in PBS containing 1%
paraformaldehyde. For each specimen, between 500,000 and 1,000,000 total events
were acquired on a modified flow cytometer (LSRII; BD Immunocytometry Systems).
Antibody capture beads (BD Biosciences) were used to prepare individual compensation
tubes for each antibody used in the experiment. Data analysis was performed using
FlowJo version 8.8.2 (TreeStar).
For analysis of NK cell conjugation with target cells and degranulation in Chapter 3,
5x105 721.221 target cells were washed, resuspended in 5x10-5M PKH26 cell membrane
dye (Sigma Aldrich) for 5min at 25°C, and labeling halted by the addition of FBS.
Labeled target cells were then washed and allowed to conjugate with GFP-myosin
expressing YTS cells at a 1:2 ratio in the presence of 1.2ng/µL PE-Cy5-conjugated
CD107a antibody (eBioscience) at 37°C, after which conjugates were fixed with 1%
paraformaldehyde and evaluated by FACS.
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NK cell functional assays
Myosin II inhibitors.
NK cells were pre-incubated with 40 µM ML-9 (Sigma-Aldrich) in 0.5% ethanol, or 75
µM blebbistatin (Sigma-Aldrich) in 0.0045% DMSO, for 30 min at 37ºC where indicated,
as previously described (Andzelm et al., 2007).
51

Cr release cytotoxicity assay.
Cytolytic activity was measured by 51Cr release assay, and where specified, lytic

units calculated as described (Orange et al., 2002). For cytotoxicity assay with isolated
lytic granules, 3 x 106 cell equivalents of each density gradient fraction were washed and
resuspended in PBS, then added to 1 x 104 51Cr–loaded 721.221 or KT86 target cells in
HBSS along with 2 mM CaCl2. To control for the protein contained in added granule
fractions, target cells used for measuring the spontaneous release of 51Cr were
suspended in 0.03% BSA in PBS with 2 mM CaCl2.
NK cell IFN-γ secretion.
YTS NK cells were pre-incubated with blebbistatin or vehicle for 30 min at 37˚C,
after which media or 721.221 target cells at a 2:1 effector to target cell ratio were added
for 0, 4, or 22 hours (Chapter 2), or for 0 and 24 hours (Chapter 3). After incubation, cell
supernatants were removed and frozen at -80˚C and then batch analyzed by IFN-γ
ELISA (R&D Systems). For analysis of eNK IFN-γ secretion, eNK cells were preincubated with blebbistatin or vehicle, then incubated with 721.221 cells as described
above for 22 hours.

Biochemical assays
Immunoprecipitation.
For immunoprecipitation of GFP-tagged myosin from whole cell lysate, 3x106 GFPmyosin expressing YTS cells were lysed in ice-cold lysis buffer (25mM Tris-Cl (pH 7.5),
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150mM NaCl, 5mM MgCl2, 1% Nonidet P-40, 1mM DTT, 5% glycerol). Lysates were
pre-cleared by centrifugation at 14,000xg for 10 min, then incubated at 4°C for 1h on a
rotating platform with Protein G-Agarose beads (Invitrogen) and anti-GFP antibody
(Clontech 632460). For immunoprecipitation from lytic granules, lytic granules were
isolated as described below and resuspended in 2M NaCl for 20min at 25°C, then
subjected to centrifugation at 18,000xg for 15min. Supernatants from salt-treated
granules were used for immunoprecipitation as described above.
Western blot.
For Western blotting of total lysate, cells were lysed in ice-cold lysis buffer (25 mM
Tris-Cl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP-40, 1 mM DTT, 5% glycerol).
Proteins from 2.5 x 106 cell equivalents per sample were separated on a 4-12% Bis-Tris
density gradient gel (Invitrogen) and transferred to nitrocellulose membranes
(Invitrogen), which were blocked in 3% BSA and 140 mM NaCl Tris-buffered saline
(TBS) and then incubated with the antibodies indicated below. For Western blotting of
isolated lytic granules and related samples, 4-5.6 x 105 cell equivalents of density
gradient fractions were separated and transferred as described above. Membranes
were incubated with the following antibodies: anti-myosin IIA (Sigma M8064), antimyosin IIA (Abcam 55456), anti-myosin IIA phosphoserine 1943 (ECM Biosciences),
anti-granzyme B (Sigma), anti-actin (Sigma), anti-perforin (Diaclone) or anti-LAMP-1 (BD
Biosciences). The Sigma antibody to myosin IIA detects the C-terminus of the protein,
while the Abcam antibody detects an internal epitope which is not truncated in the 1933x
protein. Bound antibodies were detected with anti-rabbit or anti-mouse IgG coupled to
fluorophores (AlexaFluor 680, Molecular Probes; IRDye 800, Rockland), and imaged
using the Odyssey Infrared Imaging System (Li-Cor Biosciences). Densitometric
analysis was performed for Western blots using Li-Cor Odyssey software.
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Isolation of lytic granules from NK cells.
1-3 x 108 YTS or YTS-Myosin II-GFP NK cells were lysed and homogenized using a
Dounce homogenizer. The homogenized lysates were subjected to centrifugation at
1000g to remove the nuclei. The postnuclear lysate (PNL) was subjected to
centrifugation at 18,000g to pellet the lytic granules, yielding the crude lysosomal fraction
(CLF). The CLF was resuspended in extraction buffer and subjected to density gradient
ultracentrifugation at 150,000g on an 8-27% Optiprep gradient (Lysosomal Isolation Kit,
Sigma-Aldrich, or Lysosome Enrichment Kit, Pierce). Fractions of 0.53 mL were
harvested for further analysis. For isolation of lytic granules from human NK cells, 1 x
108 NK cells were isolated as described above from peripheral blood, and granule
isolation was performed as described above. Where specified for comparison to
conjugated cell granules, 2 x 108 YTS or YTS-Myosin IIA-GFP NK cells and 1 x 108
KT86 target cells were either incubated together at 37˚C for 30 min before being lysed,
or were lysed and homogenized separately, and then mixed. The lysates of both cell
types were then subjected to the lytic granule isolation procedure described above.
Biotinylation of isolated lytic granules.
The lytic granule density gradient fraction found by Western blot to contain the most
granzyme B and myosin IIA was washed in PBS and divided into two equal-volume
portions. One portion was incubated with PBS pH 8.0 alone, while the second portion
was incubated with EZ-Link Sulfo-NHS-SS-Biotin (Pierce) in PBS pH 8.0 at RT for 30
min following manufacturer’s instructions. Both portions were then washed 2X with icecold PBS and lysed in 1% NP-40. Lysed granules were pre-cleared at 8200g for 10
minutes, then incubated with streptavidin-agarose beads (Millipore) at 4˚C for 1 hour.
Beads were pelleted at 8200g, then washed 3X with ice-cold PBS. Immunoprecipitated
proteins were released from beads by boiling in LDS sample buffer (Invitrogen) and
subjected to gel electrophoresis and Western blot as described above.

92

Serine esterase assay.
Equal volumes of each lytic granule isolation density gradient fraction were placed
into a 96-well plate, to which a substrate solution consisting of PBS containing 9.8 mM
HEPES (Gibco), 196 µM N-a-Cbz-L-lysine thiobenzyl ester hydrochloride (BLT, Sigma)
in 1:1 acetic acid:ethanol, and 218 µM 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB, Sigma)
in ethanol was added. Whole cell lysate from 1-2.5 x 105 YTS cells was added to
separate wells as a control. Samples were incubated with substrate solution for 30 min
at 37˚C, and following incubation, absorbance was measured at 415 nm.
Actin-binding centrifugation assay.
F-actin was generated from purified G-actin using standardized reagents
(Cytoskeleton, Inc.) according to manufacturer’s instructions and allowed to stabilize for
14 hours at 23°C. Isolated lytic granule samples from one fraction of the density
gradient were incubated for 30 min at 23°C in the presence or absence of 3.83 µM Factin. Actin bundling protein α-actinin was added at 20 µg/mL as a positive control.
Samples were then precipitated by centrifugation at 18,000g, a force lower than needed
to precipitate F-actin but suitable for precipitating lytic granules. The precipitate and
supernatant were evaluated for the presence of actin and granzyme B by Western blot.
Actin-binding flow chamber assay.
Purified G-Actin (11.5 µM, Cytoskeleton, Inc.) was polymerized using F-actin
polymerization buffer (Cytoskeleton, Inc.) in the presence of 11 µM unlabeled phalloidin
(Sigma-Aldrich), 0.85 µM biotinylated phalloidin (Molecular Probes), and 1.41 µM Alexa
Fluor 647-labeled phalloidin (Molecular Probes), then allowed to stabilize for 4 hours at
23°C. 50 mm coverslips (VWR) were coated with 10 µg/mL biotinylated BSA (Pierce),
followed by 10 µg/mL streptavidin (Jackson ImmunoResearch), and where specified,
followed by polymerized, phalloidin-stabilized F-actin. A flow chamber was created by
adhering a 40 mm coverslip (VWR) to each protein-coated coverslip using silicone
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grease. 150 µL of isolated lytic granules from a density gradient fraction enriched in
myosin IIA and granzyme B were washed in PBS at 18,000g, incubated with Lysotracker
Red DND-99 for 30 min at 37˚C, washed, and resuspended in physiologic salt buffer (25
mM KCl, 2 mM MgCl2, 20 mM HEPES pH 7.6). Where specified, granules were also
incubated with and maintained in 75 µM blebbistatin. Lytic granules were added to the
flow chamber dropwise, and buffer drawn through the chamber using Whatman paper at
the opposite end. After granules had adhered to the slide despite continued buffer flow,
high-salt/ATP (100 mM KCl, 2 mM MgCl2, 20 mM HEPES, pH 7.6, 5 mM ATP) solution
was added to the chamber. Granules were allowed to flow through or adhere to the
chamber for 1-2 minutes before imaging with an Olympus IX-81 spinning disk confocal
microscope at maximum speed (approximately 5 images/sec). Images were analyzed
using Volocity software, in which granules were defined as objects containing 2 SD or
higher GFP intensity (for Myosin IIA-GFP cell granules) or Lysotracker Green intensity
(for human NK granules). Objects less than 1 µm2 in area were excluded as debris.
The “Track Objects” function in Volocity was used following the “Shortest Path” tracking
model, identifying moving objects as tracks. Broken tracks were joined by the program
using a maximum distance between objects of 20 µm to avoid identifying one moving
granule as multiple tracks, and to allow accurate joining of fast-moving objects. Tracks
with displacement greater than 5 µm were considered to be lytic granules in motion in
the flow chamber, and were counted, then divided by the duration of the video to control
for differences in imaging time. For visualization of BSA/SA- and BSA/SA/Actin-coated
flow chambers, separate flow chambers were made containing BSA/SA or BSA/SA and
F-actin, stabilized with 11 µM AlexaFluor 488-labeled phalloidin (Molecular Probes).
Flow chambers were visualized by TIRF microscopy as described above.
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Mass spectrometry.
Fractions of the lytic granule density gradient shown by Western blot to be enriched
in granzyme B and myosin IIA were separated by electrophoresis on a 4-12% Bis-Tris
density gradient gel (Invitrogen) which was stained with colloidal Coomassie. Individual
bands of interest were excised, digested with trypsin, and subjected to vacuum matrixassisted laser desorption (vMALDI) mass spectrometry as described (Krzewski et al.,
2006) in the Stokes Protein Core Facility of the Children’s Hospital of Philadelphia. MS
data was analyzed using Scaffold software (Proteome Software Inc).

Imaging and image analysis
Fixed cell microscopy.
Conjugates between NK and target cells at a 2:1 ratio were formed in suspension for
20 min and adhered to poly-L-lysine-coated glass slides (Polyprep, Sigma-Aldrich) for 15
min, all at 37°C, as described (Sanborn et al., 2010). Fixing, permeabilization, and
staining were performed as previously (Sanborn et al., 2010), except the following
reagents were used in the specified sequence. For Chapter 2, the sequences used
were: 1) anti-myosin IIA (Sigma) or rabbit IgG control (Sigma), or anti-myosin IIA
(Abcam) or mouse IgG control; 2) anti-rabbit Pacific Blue (Invitrogen) or anti-mouse
Pacific Blue (Invitrogen); 3) rabbit IgG (to block nonspecific binding); 4) unconjugated or
FITC-conjugated anti-perforin clone ∆G9 (BD) or nonspecific IgG clone MOPC21 (BD,
as a control); 5) Alexa Fluor 647-conjugated highly cross-adsorbed goat anti-mouse
(Invitrogen), or AlexaFluor 647-conjugated phalloidin or 647-conjugated streptavidin
control (Invitrogen). For Chapter 3, the sequence used was: 1) unconjugated antiperforin clone ∆G9 (BD) or nonspecific IgG clone MOPC21 (BD, as a control); 2) Pacific
Blue-conjugated goat anti-mouse (Invitrogen) and AlexaFluor 647-conjugated phalloidin
(Invitrogen). All antibodies were used in the range of 0.6-20 µg/mL. Slides were
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covered with 0.15 mm coverslips (VWR Scientific) using mounting medium (Molecular
Probes). Imaging was performed using a spinning disk confocal microscope (Olympus
IX-81 DSU), and images analyzed using Volocity software (Improvision). For evaluation
of myosin IIA, GFP, actin, and perforin localization throughout the cell volume, 20-30
images were acquired through the z-axis at 0.5 µm intervals and reconstructed using
Volocity software.
In all experiments, detection settings were adjusted so that control-stained samples
were uniformly negative and experimentally stained samples were not saturating or
emitting signal detectable using filter sets intended for imaging other fluorophores.
Settings were not adjusted throughout the experiment to allow for quantitative
assessment of signals. The accumulation of fluorescent molecules was examined using
the intensity threshold of 1.5-3.5 SD higher than the mean intensity of the fluorophore
within the field. The area occupied by an accumulated fluorescence intensity was
measured using this threshold, and the area of colocalization between different
fluorescent molecules was determined by measuring the area containing two or more
accumulated fluorophores. The percentage colocalized was determined by comparing
the area of colocalization to the total area occupied by a certain fluorophore. Images
shown have a similar intensity threshold applied for visualization as for analysis in order
to facilitate the visualization of the fluorescent signal measured. Analysis of perforin
polarization to the IS was performed as described previously for MTOC polarization
(Banerjee et al., 2007), using perforin fluorescence in place of α-tubulin. Quantitative
analysis of F-actin accumulation at the IS was performed as described previously
(Banerjee et al., 2007), with the following modification: a series of 1 µm2 regions were
generated to cover the IS, and the mean F-actin intensity measured and multiplied by
the area of F-actin determined by applying the same threshold to all areas sampled.
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Live cell microscopy.
NK cells were loaded with Lysotracker Red DND-99 (Molecular Probes), incubated
for 30 min at 37°C, washed, and resuspended in RPMI with 10% FCS. KT86 or 721.221
target cells were adhered to a ∆T dish (Bioptechs) pre-coated with anti-CD48 (BD, for
721.221) or anti-CD58 (BD, for KT86) mAb for 30 min at 37°C. Lysotracker-loaded NK
cells were introduced to the ∆T dish at a 1.5:1 effector to target ratio, and cells were
imaged in a single z-plane using an Olympus IX-81 spinning disk confocal microscope
and Volocity Software (Improvision) every 15 seconds over the course of 20-30 min of
conjugation. Temperature was maintained at 37°C over the course of the experiment
using ∆T dish heater and objective heater units (Bioptechs). For analysis of
colocalization over time, 3-5 images were chosen from ≥8 conjugates which contained
visible lytic granules and represented stages of IS formation (recognition of target cell,
lytic granule clustering and initial polarization, final stages of granule polarization).
Values were averaged with others representing similar time after conjugation binned by
1 min intervals. Accumulation of fluorescent molecules was analyzed as described
above for fixed cells, using a similar intensity threshold to define accumulation of
fluorescent signal. The area occupied by accumulated fluorescence was measured and
the percent colocalized area determined for each time point. Images shown have a
similar intensity threshold applied for visualization as for analysis in order to facilitate the
visualization of the fluorescent signal measured.
Total internal reflection fluorescence (TIRF) microscopy.
4x105 YTS cells were loaded with 10 µM Lysotracker Green (Invitrogen),
resuspended in 0.5 mL RPMI with 10% FCS, and added to anti-CD28 coated ∆T dishes
(Bioptechs) heated to 37oC. Cells were imaged through the z-axis 25 min after addition,
using confocal microscopy to identify cells with granules polarized to the anti-CD28coated glass. Cells were then visualized using a 90o side port on the same microscope
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outfitted with a TIRF illuminator (Olympus) and an Argon 488nm laser (Melles Griot) with
a 60x 1.45 NA objective. Images were acquired in TIRF mode at the interface between
the cell and glass over 30s at a rate of 5 images/sec. Image streams were analyzed by
cropping to the cell of interest, then further cropping to the cell footprint by applying an
inclusive classifier to detect objects that fell above the mean intensity of the image.
Objects within the cell having an intensity >3 SD above the mean intensity of all pixels
and >0.05 µm2 were included for analysis. Object tracks were identified over time using
the Volocity Shortest Path tracking model set to join broken tracks with a maximum
distance between objects of 0.05 µm. Objects not assigned to a track, i.e. those that
were present for only one timepoint, were excluded from analysis.
Electron microscopy (EM).
For EM of isolated lytic granules in Chapter 2, 200 µL of isolated lytic granules from
YTS NK cells was washed in PBS at 18,000g and resuspended in 1 mL of immuno-EM
fixative (4% paraformaldehyde, 0.1% glutaraldehyde, 0.1 M sodium cacodylate buffer pH
7.4) for 18 hours at 4ºC. After subsequent dehydration in ethanol, the sample was
embedded in L.R.White resin and polymerized with UV light at -20ºC. Ultrathin sections
on nickel grids were treated with a blocking solution containing ovalbumin and cold water
fish skin gelatin prior to incubation with anti-myosin IIA antibody (Sigma). After multiple
PBS washes, sections were treated with a goat anti-rabbit secondary antibody
conjugated to 6 nm gold particles. Sections were imaged in the Biomedical Imaging
Core Facility of the University of Pennsylvania using a JEOL 1010 electron microscope
fitted with a Hamamatsu digital camera system. True immunogold labeling in images
was identified using AMT imaging software by reducing gamma to 0.3. Data shown,
however, represent the original unmodified image.
For EM of isolated lytic granules in Chapter 3, lytic granules were isolated as
described above, then resuspended in PBS containing protease and phosphatase
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inhibitor (HALT, Pierce) and seeded on glass coverslips coated with anti-myosin IIA
antibody (Sigma) for 30 minutes at 37°C. Coverslips containing lytic granules were
prepared for platinum rotary shadowing EM as previously described (Orange et al.,
2011).
STED microscopy.
For STED microscopy, lytic granules were isolated from YTS cells as described
above and seeded on Poly-L-lysine coated glass slides for 60 minutes at 37°C.
Samples were prepared for imaging as previously described, and were treated with
rabbit anti-myosin IIA antibody (Sigma), followed by DyLight 488 conjugated goat antimouse antibody (BioLegend). Samples were mounted using Prolong mounting medium
containing anti-fade (Invitrogen). STED images were acquired with a Leica STED CW
system using an HCX APO 100X/1.4 oil STED objective. Samples were excited with a
488nm argon laser and depleted with a 592nm laser.

Statistical analysis
For fixed and live cell microscopy, the minimum number of cells evaluated in a given
experiment was determined using a sample size calculation based upon preliminary
data, with α and β error levels of 1%. For statistical analyses, differences between cell
types or conditions were determined using an unpaired two-tailed Student’s t test, an
exact Wilcoxon-Mann-Whitney test, or a Wilcoxon matched pairs test. Differences were
considered significant if p<0.05.
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